[
    {
        "text": "uh thank you m and Kimi for the",
        "start": 0.56,
        "duration": 5.52
    },
    {
        "text": "invitation and thanks Jun for the kind",
        "start": 2.76,
        "duration": 6.919
    },
    {
        "text": "introduction um yeah so I am now at the",
        "start": 6.08,
        "duration": 6.639
    },
    {
        "text": "company the name of the company is gv20",
        "start": 9.679,
        "duration": 5.561
    },
    {
        "text": "Therapeutics so some of you might wonder",
        "start": 12.719,
        "duration": 4.32
    },
    {
        "text": "whether this has anything to do with",
        "start": 15.24,
        "duration": 4.24
    },
    {
        "text": "Google Venture um unfortunately it",
        "start": 17.039,
        "duration": 5.24
    },
    {
        "text": "doesn't when we started the company in",
        "start": 19.48,
        "duration": 5.879
    },
    {
        "text": "2016 the the core technology was crisper",
        "start": 22.279,
        "duration": 5.76
    },
    {
        "text": "screens my lab started using crisper",
        "start": 25.359,
        "duration": 5.08
    },
    {
        "text": "screens for oncology and immune ology",
        "start": 28.039,
        "duration": 4.04
    },
    {
        "text": "studies in",
        "start": 30.439,
        "duration": 4.28
    },
    {
        "text": "2014 um and we also developed many",
        "start": 32.079,
        "duration": 4.921
    },
    {
        "text": "algorithms for developing more efficient",
        "start": 34.719,
        "duration": 6.081
    },
    {
        "text": "crisper screens and for um analyzing the",
        "start": 37.0,
        "duration": 5.92
    },
    {
        "text": "high surut sequencing data to get hits",
        "start": 40.8,
        "duration": 4.32
    },
    {
        "text": "from crisper screens and so when we",
        "start": 42.92,
        "duration": 4.799
    },
    {
        "text": "started this company um the broad",
        "start": 45.12,
        "duration": 4.72
    },
    {
        "text": "Institute crisper screen technology",
        "start": 47.719,
        "duration": 5.561
    },
    {
        "text": "platform is called Achilles Hill project",
        "start": 49.84,
        "duration": 5.039
    },
    {
        "text": "uh so we were trying to see whether",
        "start": 53.28,
        "duration": 4.079
    },
    {
        "text": "there's another name we can say like",
        "start": 54.879,
        "duration": 4.721
    },
    {
        "text": "cancer vulnerability uh so in the",
        "start": 57.359,
        "duration": 4.441
    },
    {
        "text": "Chinese is acupuncture point there are",
        "start": 59.6,
        "duration": 4.919
    },
    {
        "text": "some uh acupuncture point on the back of",
        "start": 61.8,
        "duration": 4.96
    },
    {
        "text": "the spine like on the spine from the",
        "start": 64.519,
        "duration": 5.041
    },
    {
        "text": "tailbone is GV one and two and three all",
        "start": 66.76,
        "duration": 5.32
    },
    {
        "text": "the way up and on the top of the head is",
        "start": 69.56,
        "duration": 5.64
    },
    {
        "text": "gv20 uh by so we are trying to use",
        "start": 72.08,
        "duration": 7.32
    },
    {
        "text": "genomics and computation to find cancer",
        "start": 75.2,
        "duration": 6.64
    },
    {
        "text": "vulnerabilities um so let me start the",
        "start": 79.4,
        "duration": 5.12
    },
    {
        "text": "talk with a question do you know the to",
        "start": 81.84,
        "duration": 6.68
    },
    {
        "text": "selling cancer drug in",
        "start": 84.52,
        "duration": 4.0
    },
    {
        "text": "2022",
        "start": 88.84,
        "duration": 3.0
    },
    {
        "text": "um yeah it's ENT pd1 drug from Merk",
        "start": 94.36,
        "duration": 6.719
    },
    {
        "text": "right Kuda right it's the yeah number",
        "start": 98.24,
        "duration": 5.879
    },
    {
        "text": "one and of course uh BMS also sell a",
        "start": 101.079,
        "duration": 6.601
    },
    {
        "text": "very similar drug of Divo and um Ro",
        "start": 104.119,
        "duration": 8.0
    },
    {
        "text": "sells a related drug anti pdl1 and so",
        "start": 107.68,
        "duration": 6.96
    },
    {
        "text": "together these three drugs sold for over",
        "start": 112.119,
        "duration": 5.96
    },
    {
        "text": "$ 35 billion doar in",
        "start": 114.64,
        "duration": 5.799
    },
    {
        "text": "Revenue so what are the conventional",
        "start": 118.079,
        "duration": 4.96
    },
    {
        "text": "approach to discover a drug like anti-",
        "start": 120.439,
        "duration": 5.881
    },
    {
        "text": "pd1 or anti pdl1 the process usually",
        "start": 123.039,
        "duration": 6.481
    },
    {
        "text": "works like this um it's from the target",
        "start": 126.32,
        "duration": 5.76
    },
    {
        "text": "to the mechanism to the drug so first",
        "start": 129.52,
        "duration": 4.28
    },
    {
        "text": "you have to know there's a gene called a",
        "start": 132.08,
        "duration": 4.08
    },
    {
        "text": "pd1 you need to understand its function",
        "start": 133.8,
        "duration": 5.079
    },
    {
        "text": "or the mechanism so pd1 is a gene that's",
        "start": 136.16,
        "duration": 5.24
    },
    {
        "text": "highly expressed on the te- cells and it",
        "start": 138.879,
        "duration": 5.801
    },
    {
        "text": "interacts with uh pdl1 on the antigen",
        "start": 141.4,
        "duration": 5.64
    },
    {
        "text": "presenting cells and this pair of",
        "start": 144.68,
        "duration": 4.4
    },
    {
        "text": "interaction makes the t- cell in a",
        "start": 147.04,
        "duration": 5.279
    },
    {
        "text": "dysfunctional stage a state therefore",
        "start": 149.08,
        "duration": 5.159
    },
    {
        "text": "you can develop an antibody either",
        "start": 152.319,
        "duration": 5.361
    },
    {
        "text": "against the pd1 or pdr1 to block this",
        "start": 154.239,
        "duration": 5.521
    },
    {
        "text": "interaction and therefore then when the",
        "start": 157.68,
        "duration": 4.4
    },
    {
        "text": "te- cells are activated when the t- cell",
        "start": 159.76,
        "duration": 4.68
    },
    {
        "text": "receptor recognize the cancer cell as",
        "start": 162.08,
        "duration": 5.32
    },
    {
        "text": "nonself then the pd1 antibody can",
        "start": 164.44,
        "duration": 5.799
    },
    {
        "text": "maintain T cell in a constant uh",
        "start": 167.4,
        "duration": 5.559
    },
    {
        "text": "activated stage or maintain the energy",
        "start": 170.239,
        "duration": 5.801
    },
    {
        "text": "the the activity of the te- cells so",
        "start": 172.959,
        "duration": 4.881
    },
    {
        "text": "overall this is a pretty long and",
        "start": 176.04,
        "duration": 3.76
    },
    {
        "text": "expensive process you have to understand",
        "start": 177.84,
        "duration": 4.44
    },
    {
        "text": "the gene know this function before you",
        "start": 179.8,
        "duration": 3.719
    },
    {
        "text": "can develop a",
        "start": 182.28,
        "duration": 4.0
    },
    {
        "text": "drug but do you know that um cancer",
        "start": 183.519,
        "duration": 5.64
    },
    {
        "text": "patient in their tumors already make",
        "start": 186.28,
        "duration": 5.599
    },
    {
        "text": "anti pd1 anti pdr1",
        "start": 189.159,
        "duration": 5.241
    },
    {
        "text": "antibodies um this is actually the",
        "start": 191.879,
        "duration": 7.561
    },
    {
        "text": "hypothesis when um we um are taking to",
        "start": 194.4,
        "duration": 8.32
    },
    {
        "text": "uh develop in the company and so in",
        "start": 199.44,
        "duration": 4.96
    },
    {
        "text": "recent years there are increasing",
        "start": 202.72,
        "duration": 3.799
    },
    {
        "text": "realization in the tumors there are",
        "start": 204.4,
        "duration": 5.479
    },
    {
        "text": "small lymph nodes and so in there um the",
        "start": 206.519,
        "duration": 6.241
    },
    {
        "text": "tumor has the the dendritic cells are",
        "start": 209.879,
        "duration": 4.64
    },
    {
        "text": "presenting the tumor antigen to our",
        "start": 212.76,
        "duration": 4.199
    },
    {
        "text": "immune system and so this tertiary",
        "start": 214.519,
        "duration": 4.161
    },
    {
        "text": "lymphoid structure these tiny lymph",
        "start": 216.959,
        "duration": 4.48
    },
    {
        "text": "nodes are proliferating t- cells and B",
        "start": 218.68,
        "duration": 6.759
    },
    {
        "text": "cells um to against the tumor antigen um",
        "start": 221.439,
        "duration": 6.401
    },
    {
        "text": "especially we're interested in B cells",
        "start": 225.439,
        "duration": 4.401
    },
    {
        "text": "so these B cells in the patient tumors",
        "start": 227.84,
        "duration": 3.92
    },
    {
        "text": "in these little lymph nodes they can",
        "start": 229.84,
        "duration": 4.64
    },
    {
        "text": "recognize the relevant tumor antigen it",
        "start": 231.76,
        "duration": 5.039
    },
    {
        "text": "can get activated and then gradually",
        "start": 234.48,
        "duration": 5.2
    },
    {
        "text": "evolve to optimize antibodies again",
        "start": 236.799,
        "duration": 5.36
    },
    {
        "text": "against the tumor antigen and then Mount",
        "start": 239.68,
        "duration": 4.199
    },
    {
        "text": "attack against the",
        "start": 242.159,
        "duration": 4.72
    },
    {
        "text": "tumor unfortunately even though some of",
        "start": 243.879,
        "duration": 5.521
    },
    {
        "text": "these patients are making perfectly good",
        "start": 246.879,
        "duration": 4.521
    },
    {
        "text": "anti-tumor antibodies they are",
        "start": 249.4,
        "duration": 4.759
    },
    {
        "text": "insufficient to really defeat the tumors",
        "start": 251.4,
        "duration": 4.679
    },
    {
        "text": "and there are two reasons for this the",
        "start": 254.159,
        "duration": 4.76
    },
    {
        "text": "first is that they don't make enough so",
        "start": 256.079,
        "duration": 5.44
    },
    {
        "text": "you can imagine when you have a war just",
        "start": 258.919,
        "duration": 4.761
    },
    {
        "text": "having a small group of good soldiers",
        "start": 261.519,
        "duration": 4.12
    },
    {
        "text": "are insufficient you really need a whole",
        "start": 263.68,
        "duration": 4.72
    },
    {
        "text": "Army of good soldiers uh so that the",
        "start": 265.639,
        "duration": 5.761
    },
    {
        "text": "amount is one thing the second is that",
        "start": 268.4,
        "duration": 5.359
    },
    {
        "text": "when the antibody is still on the B",
        "start": 271.4,
        "duration": 5.32
    },
    {
        "text": "cells or on the plasma cells the the the",
        "start": 273.759,
        "duration": 5.321
    },
    {
        "text": "the B cells themselves can still go",
        "start": 276.72,
        "duration": 6.6
    },
    {
        "text": "through a process to shift the FC and so",
        "start": 279.08,
        "duration": 7.52
    },
    {
        "text": "if you look at the antibody the fa the",
        "start": 283.32,
        "duration": 6.52
    },
    {
        "text": "Fab region recognize the tumor antigen",
        "start": 286.6,
        "duration": 5.2
    },
    {
        "text": "but the FC region they call out a",
        "start": 289.84,
        "duration": 4.079
    },
    {
        "text": "different immune help so when the",
        "start": 291.8,
        "duration": 4.88
    },
    {
        "text": "antibody is uh in a B cell is a naive B",
        "start": 293.919,
        "duration": 5.681
    },
    {
        "text": "cell it makes IGM antibody when it's",
        "start": 296.68,
        "duration": 6.04
    },
    {
        "text": "activated it makes the IGG antibody but",
        "start": 299.6,
        "duration": 5.2
    },
    {
        "text": "then the cyto Kine environment in the",
        "start": 302.72,
        "duration": 5.4
    },
    {
        "text": "tumor can induce the B cell to shift",
        "start": 304.8,
        "duration": 7.04
    },
    {
        "text": "from a IGG antibody to an IG antibody",
        "start": 308.12,
        "duration": 5.639
    },
    {
        "text": "and we believe once the antibody is a",
        "start": 311.84,
        "duration": 4.6
    },
    {
        "text": "IGA antibody it's no longer tumor",
        "start": 313.759,
        "duration": 4.681
    },
    {
        "text": "killing it's actually even tumor",
        "start": 316.44,
        "duration": 5.8
    },
    {
        "text": "protective so our hypothesis was that",
        "start": 318.44,
        "duration": 6.879
    },
    {
        "text": "normally IGA antibody actually appears",
        "start": 322.24,
        "duration": 6.2
    },
    {
        "text": "in the mucosal tissues like your airwave",
        "start": 325.319,
        "duration": 4.761
    },
    {
        "text": "and your GI track",
        "start": 328.44,
        "duration": 4.0
    },
    {
        "text": "because the air you breathe from outside",
        "start": 330.08,
        "duration": 4.6
    },
    {
        "text": "the food you eat from outside clearly",
        "start": 332.44,
        "duration": 5.28
    },
    {
        "text": "contain nonself things and there's no",
        "start": 334.68,
        "duration": 5.76
    },
    {
        "text": "point to get your alarm system to get",
        "start": 337.72,
        "duration": 5.36
    },
    {
        "text": "your immune system alarmed against these",
        "start": 340.44,
        "duration": 6.319
    },
    {
        "text": "food or and attack them and so once the",
        "start": 343.08,
        "duration": 6.04
    },
    {
        "text": "we we hypothesize this IGA antibody",
        "start": 346.759,
        "duration": 4.081
    },
    {
        "text": "that's lining your gut tissue is",
        "start": 349.12,
        "duration": 3.48
    },
    {
        "text": "actually suppressing the nearby immune",
        "start": 350.84,
        "duration": 4.56
    },
    {
        "text": "system and therefore um when the cancer",
        "start": 352.6,
        "duration": 5.76
    },
    {
        "text": "cell in you know in a tumor you know",
        "start": 355.4,
        "duration": 5.04
    },
    {
        "text": "cancer cell never do anything Den Noble",
        "start": 358.36,
        "duration": 3.76
    },
    {
        "text": "they always learn something from stem",
        "start": 360.44,
        "duration": 4.4
    },
    {
        "text": "cells from other cells and so cancer",
        "start": 362.12,
        "duration": 5.32
    },
    {
        "text": "cell realize that if it's actually",
        "start": 364.84,
        "duration": 4.52
    },
    {
        "text": "producing the cyto kind the B cells can",
        "start": 367.44,
        "duration": 4.96
    },
    {
        "text": "shift the antibody from IGG to an IGA",
        "start": 369.36,
        "duration": 4.6
    },
    {
        "text": "and then this piece of tumor will look",
        "start": 372.4,
        "duration": 3.4
    },
    {
        "text": "like a piece of food to the immune",
        "start": 373.96,
        "duration": 3.84
    },
    {
        "text": "system and then your immune system",
        "start": 375.8,
        "duration": 4.119
    },
    {
        "text": "wouldn't attack it right you become",
        "start": 377.8,
        "duration": 4.76
    },
    {
        "text": "protumor so the way we came up with the",
        "start": 379.919,
        "duration": 5.161
    },
    {
        "text": "H hypothesis was to look at the tcga",
        "start": 382.56,
        "duration": 6.359
    },
    {
        "text": "data so in the uh the amount of B cells",
        "start": 385.08,
        "duration": 5.76
    },
    {
        "text": "in the T usually if you have more B",
        "start": 388.919,
        "duration": 4.801
    },
    {
        "text": "cells is good but the percentage of IgA",
        "start": 390.84,
        "duration": 4.88
    },
    {
        "text": "antibody is actually bad when you have",
        "start": 393.72,
        "duration": 5.4
    },
    {
        "text": "more IGA the patient actually do worse",
        "start": 395.72,
        "duration": 5.879
    },
    {
        "text": "we we then also checked the literature",
        "start": 399.12,
        "duration": 4.12
    },
    {
        "text": "um there was some earlier work from",
        "start": 401.599,
        "duration": 3.921
    },
    {
        "text": "Michael karim's SL to show this and",
        "start": 403.24,
        "duration": 3.72
    },
    {
        "text": "later on there was a special",
        "start": 405.52,
        "duration": 6.399
    },
    {
        "text": "transcriptomic work um to um from uh um",
        "start": 406.96,
        "duration": 7.4
    },
    {
        "text": "death Mar Wolf's group they also show",
        "start": 411.919,
        "duration": 6.041
    },
    {
        "text": "that basically the B cells are matured",
        "start": 414.36,
        "duration": 6.0
    },
    {
        "text": "in this tertiary lympho structure and",
        "start": 417.96,
        "duration": 4.679
    },
    {
        "text": "then through the fiberblast tract it",
        "start": 420.36,
        "duration": 5.679
    },
    {
        "text": "will migrate to the tumor Niche and if",
        "start": 422.639,
        "duration": 6.12
    },
    {
        "text": "the the B cells going to that location",
        "start": 426.039,
        "duration": 5.961
    },
    {
        "text": "is producing IGG antibody like this one",
        "start": 428.759,
        "duration": 5.601
    },
    {
        "text": "then the adjacent cancer cells are more",
        "start": 432.0,
        "duration": 5.44
    },
    {
        "text": "apoptotic whereas if it's producing IGA",
        "start": 434.36,
        "duration": 5.559
    },
    {
        "text": "antibodies then the nearby uh cancer",
        "start": 437.44,
        "duration": 4.52
    },
    {
        "text": "cells are no longer being killed by the",
        "start": 439.919,
        "duration": 5.0
    },
    {
        "text": "B cells and antibodies and so then we",
        "start": 441.96,
        "duration": 4.919
    },
    {
        "text": "thought oh okay so the patient are",
        "start": 444.919,
        "duration": 3.601
    },
    {
        "text": "trying they're making antibody but",
        "start": 446.879,
        "duration": 3.44
    },
    {
        "text": "they're not making enough and then very",
        "start": 448.52,
        "duration": 4.359
    },
    {
        "text": "quickly the the tumor also is forcing",
        "start": 450.319,
        "duration": 5.521
    },
    {
        "text": "the B cell to shift the uh FC to the",
        "start": 452.879,
        "duration": 5.88
    },
    {
        "text": "wrong FC then it stops uh killing the",
        "start": 455.84,
        "duration": 5.96
    },
    {
        "text": "tumor therefore what if we just directly",
        "start": 458.759,
        "duration": 5.521
    },
    {
        "text": "give patient antibodies because if you",
        "start": 461.8,
        "duration": 5.56
    },
    {
        "text": "give antibody as a protein it cannot",
        "start": 464.28,
        "duration": 5.0
    },
    {
        "text": "actually shift FC it only happens on the",
        "start": 467.36,
        "duration": 4.6
    },
    {
        "text": "B cells so if we give the patient enough",
        "start": 469.28,
        "duration": 4.599
    },
    {
        "text": "of the antibody with the right those",
        "start": 471.96,
        "duration": 4.6
    },
    {
        "text": "with the right format then this could be",
        "start": 473.879,
        "duration": 5.081
    },
    {
        "text": "very powerful Therapeutics and that's",
        "start": 476.56,
        "duration": 5.639
    },
    {
        "text": "kind of the approach GB 20 is taking to",
        "start": 478.96,
        "duration": 6.0
    },
    {
        "text": "uh develop our Therapeutics where do we",
        "start": 482.199,
        "duration": 3.84
    },
    {
        "text": "get these",
        "start": 484.96,
        "duration": 3.48
    },
    {
        "text": "antibodies we are getting them from a",
        "start": 486.039,
        "duration": 5.641
    },
    {
        "text": "tumor profiles rnac profiles so nowadays",
        "start": 488.44,
        "duration": 6.36
    },
    {
        "text": "It Only Takes Two like two $300 to do",
        "start": 491.68,
        "duration": 5.639
    },
    {
        "text": "the RNA seek of a tumor and when you",
        "start": 494.8,
        "duration": 4.679
    },
    {
        "text": "sequence the RNA you don't just sequence",
        "start": 497.319,
        "duration": 4.681
    },
    {
        "text": "the cancerous cells you also sequence",
        "start": 499.479,
        "duration": 7.241
    },
    {
        "text": "the infiltrating B cells in there and um",
        "start": 502.0,
        "duration": 7.28
    },
    {
        "text": "the B cells are also making the RNA that",
        "start": 506.72,
        "duration": 4.52
    },
    {
        "text": "eventually produce the anti or translate",
        "start": 509.28,
        "duration": 4.8
    },
    {
        "text": "into the antibody the only thing is that",
        "start": 511.24,
        "duration": 4.599
    },
    {
        "text": "um in order you know like B cells have",
        "start": 514.08,
        "duration": 4.199
    },
    {
        "text": "only two copies of the DNA but it can",
        "start": 515.839,
        "duration": 4.481
    },
    {
        "text": "produce you know billions of different",
        "start": 518.279,
        "duration": 4.44
    },
    {
        "text": "type of antibodies because it goes",
        "start": 520.32,
        "duration": 5.76
    },
    {
        "text": "through a vdj recombination process but",
        "start": 522.719,
        "duration": 5.281
    },
    {
        "text": "once it creates this hypervariable",
        "start": 526.08,
        "duration": 4.8
    },
    {
        "text": "sequence to recognize potential antigens",
        "start": 528.0,
        "duration": 4.839
    },
    {
        "text": "then it's no longer mappable to the",
        "start": 530.88,
        "duration": 4.519
    },
    {
        "text": "reference genome and so when people do",
        "start": 532.839,
        "duration": 4.961
    },
    {
        "text": "RNA seek the very first step of data",
        "start": 535.399,
        "duration": 5.281
    },
    {
        "text": "analysis is to look at the RNA seek",
        "start": 537.8,
        "duration": 4.56
    },
    {
        "text": "reads and try to map them to the",
        "start": 540.68,
        "duration": 4.0
    },
    {
        "text": "reference genome and all the antibody",
        "start": 542.36,
        "duration": 5.12
    },
    {
        "text": "sequences get thrown out as unmappable",
        "start": 544.68,
        "duration": 5.599
    },
    {
        "text": "garbage as a computational biologist you",
        "start": 547.48,
        "duration": 5.12
    },
    {
        "text": "know we take pride in collecting or in",
        "start": 550.279,
        "duration": 5.601
    },
    {
        "text": "picking out gold from garbage and so um",
        "start": 552.6,
        "duration": 5.6
    },
    {
        "text": "we were thinking you know this V digit",
        "start": 555.88,
        "duration": 4.8
    },
    {
        "text": "Rec combination when it's translated",
        "start": 558.2,
        "duration": 4.759
    },
    {
        "text": "into protein the V sequence and J",
        "start": 560.68,
        "duration": 4.04
    },
    {
        "text": "sequence they have some amino acid",
        "start": 562.959,
        "duration": 4.0
    },
    {
        "text": "sequence patterns and so we try to look",
        "start": 564.72,
        "duration": 4.52
    },
    {
        "text": "at all those unmappable reads and try to",
        "start": 566.959,
        "duration": 4.12
    },
    {
        "text": "translate them into different frames and",
        "start": 569.24,
        "duration": 4.039
    },
    {
        "text": "ask which one of them contains some",
        "start": 571.079,
        "duration": 4.0
    },
    {
        "text": "patterns that they are coming from a B",
        "start": 573.279,
        "duration": 5.521
    },
    {
        "text": "cell from the V or J sequence and if so",
        "start": 575.079,
        "duration": 5.361
    },
    {
        "text": "especially for Paradigm sequence you",
        "start": 578.8,
        "duration": 3.4
    },
    {
        "text": "might have one end that mapped to either",
        "start": 580.44,
        "duration": 4.44
    },
    {
        "text": "V or J the other end is like unmappable",
        "start": 582.2,
        "duration": 5.12
    },
    {
        "text": "then we try to kind of assemble them",
        "start": 584.88,
        "duration": 4.56
    },
    {
        "text": "together by overlapping the reads and so",
        "start": 587.32,
        "duration": 4.36
    },
    {
        "text": "we can then assemble out the sequence uh",
        "start": 589.44,
        "duration": 4.88
    },
    {
        "text": "into antibodies on average from each",
        "start": 591.68,
        "duration": 5.68
    },
    {
        "text": "tumor RNA SE say in tcga we can get a",
        "start": 594.32,
        "duration": 4.88
    },
    {
        "text": "few thousand antibodies from the the",
        "start": 597.36,
        "duration": 4.96
    },
    {
        "text": "tumors so we did a comparison to say",
        "start": 599.2,
        "duration": 5.96
    },
    {
        "text": "well what if we just do tumor BCR",
        "start": 602.32,
        "duration": 4.48
    },
    {
        "text": "sequencing this is actually pretty",
        "start": 605.16,
        "duration": 3.96
    },
    {
        "text": "expensive essay to do BCR sequencing is",
        "start": 606.8,
        "duration": 4.32
    },
    {
        "text": "probably like a$ thousand doll but you",
        "start": 609.12,
        "duration": 4.48
    },
    {
        "text": "can also do RNA sequencing then run this",
        "start": 611.12,
        "duration": 5.399
    },
    {
        "text": "trust algorithm that we developed um and",
        "start": 613.6,
        "duration": 4.679
    },
    {
        "text": "so we saw that we are not able to",
        "start": 616.519,
        "duration": 5.041
    },
    {
        "text": "assemble all the the uh BCR sequence",
        "start": 618.279,
        "duration": 5.401
    },
    {
        "text": "instead we are getting the really",
        "start": 621.56,
        "duration": 4.68
    },
    {
        "text": "abundant ones that are clono expanded",
        "start": 623.68,
        "duration": 4.0
    },
    {
        "text": "therefore are more likely to be",
        "start": 626.24,
        "duration": 4.36
    },
    {
        "text": "recognized in tumor antig",
        "start": 627.68,
        "duration": 5.52
    },
    {
        "text": "and so then in 2019 we published this",
        "start": 630.6,
        "duration": 5.2
    },
    {
        "text": "paper in nature genetics um this was",
        "start": 633.2,
        "duration": 4.8
    },
    {
        "text": "actually dealing with bulk tumor",
        "start": 635.8,
        "duration": 4.68
    },
    {
        "text": "profiles since then uh we have published",
        "start": 638.0,
        "duration": 5.32
    },
    {
        "text": "another study um even if you do single",
        "start": 640.48,
        "duration": 5.52
    },
    {
        "text": "cell RNA seek but without specifically",
        "start": 643.32,
        "duration": 5.16
    },
    {
        "text": "amplifying the vdj region if you're",
        "start": 646.0,
        "duration": 6.36
    },
    {
        "text": "using the five Prime uh 10x genomics kit",
        "start": 648.48,
        "duration": 6.96
    },
    {
        "text": "um just regular 10x study we can still",
        "start": 652.36,
        "duration": 5.24
    },
    {
        "text": "use this trust algorithm to assemble the",
        "start": 655.44,
        "duration": 4.839
    },
    {
        "text": "TCR and the PCR sequence from the single",
        "start": 657.6,
        "duration": 5.96
    },
    {
        "text": "cell data anyhow the first author of The",
        "start": 660.279,
        "duration": 6.281
    },
    {
        "text": "2019 paper um decided to join the",
        "start": 663.56,
        "duration": 6.0
    },
    {
        "text": "company so we started collecting tumor",
        "start": 666.56,
        "duration": 5.16
    },
    {
        "text": "profiles and then just run this trust",
        "start": 669.56,
        "duration": 4.399
    },
    {
        "text": "algorithm and so we have like tens of",
        "start": 671.72,
        "duration": 4.32
    },
    {
        "text": "thousands of tumors and then we have",
        "start": 673.959,
        "duration": 4.88
    },
    {
        "text": "over a 100 million antibodies that we",
        "start": 676.04,
        "duration": 5.52
    },
    {
        "text": "computationally extracted from the",
        "start": 678.839,
        "duration": 5.281
    },
    {
        "text": "patient tumors and so we were kind of",
        "start": 681.56,
        "duration": 4.16
    },
    {
        "text": "thinking what are we going to do with",
        "start": 684.12,
        "duration": 3.719
    },
    {
        "text": "these antibodies and you know so one day",
        "start": 685.72,
        "duration": 4.919
    },
    {
        "text": "we thought oh maybe we can use AI to",
        "start": 687.839,
        "duration": 5.201
    },
    {
        "text": "predict the targets for these",
        "start": 690.639,
        "duration": 5.681
    },
    {
        "text": "antibodies um also we we we later also",
        "start": 693.04,
        "duration": 5.72
    },
    {
        "text": "realized using this approach we can tell",
        "start": 696.32,
        "duration": 4.48
    },
    {
        "text": "which Target are potentially more",
        "start": 698.76,
        "duration": 4.24
    },
    {
        "text": "disease relevant and in this case cancer",
        "start": 700.8,
        "duration": 4.839
    },
    {
        "text": "relevant and so later on we call this",
        "start": 703.0,
        "duration": 5.639
    },
    {
        "text": "approach simultaneous Target evaluation",
        "start": 705.639,
        "duration": 6.401
    },
    {
        "text": "and antibody Discovery so um let me",
        "start": 708.639,
        "duration": 6.32
    },
    {
        "text": "intuitively explain to you roughly how",
        "start": 712.04,
        "duration": 5.76
    },
    {
        "text": "we use AI to make the predictions um",
        "start": 714.959,
        "duration": 4.88
    },
    {
        "text": "let's think about the IM image analysis",
        "start": 717.8,
        "duration": 4.8
    },
    {
        "text": "you know AIW has really played a very",
        "start": 719.839,
        "duration": 5.8
    },
    {
        "text": "big role uh in recent years um so in",
        "start": 722.6,
        "duration": 6.239
    },
    {
        "text": "order for AI from say Google to",
        "start": 725.639,
        "duration": 5.961
    },
    {
        "text": "differentiate the image from a dog or a",
        "start": 728.839,
        "duration": 5.12
    },
    {
        "text": "cat or tiger or a lion what you need to",
        "start": 731.6,
        "duration": 5.56
    },
    {
        "text": "do is to feed this AI labeled individual",
        "start": 733.959,
        "duration": 5.841
    },
    {
        "text": "pictures of cats and dogs and so on and",
        "start": 737.16,
        "duration": 4.4
    },
    {
        "text": "you have to have sufficient number of",
        "start": 739.8,
        "duration": 3.56
    },
    {
        "text": "pictures right from different angles",
        "start": 741.56,
        "duration": 3.839
    },
    {
        "text": "from you know different uh individual",
        "start": 743.36,
        "duration": 4.88
    },
    {
        "text": "animals and so over time the AI can",
        "start": 745.399,
        "duration": 5.401
    },
    {
        "text": "automatic Ally learn the features that",
        "start": 748.24,
        "duration": 5.839
    },
    {
        "text": "can tell dog apart from a cat or a lion",
        "start": 750.8,
        "duration": 5.52
    },
    {
        "text": "and so this is automatically",
        "start": 754.079,
        "duration": 4.721
    },
    {
        "text": "learned and so for us this is actually a",
        "start": 756.32,
        "duration": 4.56
    },
    {
        "text": "pretty easy question we are dealing with",
        "start": 758.8,
        "duration": 4.88
    },
    {
        "text": "a much much harder question so imagine",
        "start": 760.88,
        "duration": 5.16
    },
    {
        "text": "you have a zoo and before you go to a",
        "start": 763.68,
        "duration": 4.24
    },
    {
        "text": "zoo you go to the website and you can",
        "start": 766.04,
        "duration": 4.32
    },
    {
        "text": "see uh say uh London Zoo have the",
        "start": 767.92,
        "duration": 4.52
    },
    {
        "text": "following animals Tokyo Zoo have",
        "start": 770.36,
        "duration": 3.96
    },
    {
        "text": "different animals San Diego zo have a",
        "start": 772.44,
        "duration": 4.32
    },
    {
        "text": "different animals and so on supposedly",
        "start": 774.32,
        "duration": 4.879
    },
    {
        "text": "on the website they don't tell you what",
        "start": 776.76,
        "duration": 5.079
    },
    {
        "text": "the animals look like you just know okay",
        "start": 779.199,
        "duration": 4.721
    },
    {
        "text": "the zoo has these animals what you can",
        "start": 781.839,
        "duration": 4.8
    },
    {
        "text": "look at are pictures taken by tourists",
        "start": 783.92,
        "duration": 5.64
    },
    {
        "text": "who visits that Zoo um and they don't",
        "start": 786.639,
        "duration": 5.64
    },
    {
        "text": "specifically label what animal each",
        "start": 789.56,
        "duration": 5.32
    },
    {
        "text": "picture belong to um but at least you",
        "start": 792.279,
        "duration": 4.961
    },
    {
        "text": "know that these pictures coming from the",
        "start": 794.88,
        "duration": 5.12
    },
    {
        "text": "London Zoo are are all pictures for the",
        "start": 797.24,
        "duration": 5.399
    },
    {
        "text": "the animals in that Zoo if we only look",
        "start": 800.0,
        "duration": 5.12
    },
    {
        "text": "at a single zoo we have no way of",
        "start": 802.639,
        "duration": 5.121
    },
    {
        "text": "telling what animals look like you know",
        "start": 805.12,
        "duration": 5.32
    },
    {
        "text": "which type how however if you have this",
        "start": 807.76,
        "duration": 5.04
    },
    {
        "text": "unlabeled picture but sufficient number",
        "start": 810.44,
        "duration": 5.04
    },
    {
        "text": "of zoos that are more or less you know",
        "start": 812.8,
        "duration": 5.76
    },
    {
        "text": "very different um then what you can say",
        "start": 815.48,
        "duration": 5.32
    },
    {
        "text": "is uh well let's look at all the zoos",
        "start": 818.56,
        "duration": 5.04
    },
    {
        "text": "that have lions and then look at all",
        "start": 820.8,
        "duration": 4.68
    },
    {
        "text": "their pictures do they have something in",
        "start": 823.6,
        "duration": 4.84
    },
    {
        "text": "common which are absent in the zoos that",
        "start": 825.48,
        "duration": 5.64
    },
    {
        "text": "don't have Lions how about tigers you",
        "start": 828.44,
        "duration": 3.959
    },
    {
        "text": "know look at all the zoos that have",
        "start": 831.12,
        "duration": 3.04
    },
    {
        "text": "tigers what do they have in common",
        "start": 832.399,
        "duration": 3.36
    },
    {
        "text": "that's absent in the zoos that don't",
        "start": 834.16,
        "duration": 4.88
    },
    {
        "text": "have tigers how about zebra you know uh",
        "start": 835.759,
        "duration": 6.121
    },
    {
        "text": "Panda and like every animal and so at",
        "start": 839.04,
        "duration": 4.719
    },
    {
        "text": "the end if you are learning this",
        "start": 841.88,
        "duration": 4.92
    },
    {
        "text": "correctly all the animals need to match",
        "start": 843.759,
        "duration": 5.0
    },
    {
        "text": "on all the zoos you have right then you",
        "start": 846.8,
        "duration": 4.76
    },
    {
        "text": "know that this AI is working but for us",
        "start": 848.759,
        "duration": 4.64
    },
    {
        "text": "to learn you know to to know that we are",
        "start": 851.56,
        "duration": 4.04
    },
    {
        "text": "learning this correctly um at least in",
        "start": 853.399,
        "duration": 4.641
    },
    {
        "text": "machine learning is by cross validation",
        "start": 855.6,
        "duration": 4.799
    },
    {
        "text": "imagine we leave some zoos out say",
        "start": 858.04,
        "duration": 4.88
    },
    {
        "text": "Zimbabwe zoo we have never seen this we",
        "start": 860.399,
        "duration": 4.041
    },
    {
        "text": "finish all the training with all the",
        "start": 862.92,
        "duration": 3.64
    },
    {
        "text": "rest of the zoos and then we finish the",
        "start": 864.44,
        "duration": 5.44
    },
    {
        "text": "training we ask um give me the pictures",
        "start": 866.56,
        "duration": 5.88
    },
    {
        "text": "from tourists coming from Zimbabwe zoo",
        "start": 869.88,
        "duration": 4.639
    },
    {
        "text": "and say if based on the pictures we can",
        "start": 872.44,
        "duration": 5.079
    },
    {
        "text": "say well they seem to have zebra giraffe",
        "start": 874.519,
        "duration": 5.88
    },
    {
        "text": "and hippo but then they don't have Panda",
        "start": 877.519,
        "duration": 5.361
    },
    {
        "text": "and Penguin and if they actually agree",
        "start": 880.399,
        "duration": 5.161
    },
    {
        "text": "with the animal in the in the zoo the",
        "start": 882.88,
        "duration": 4.6
    },
    {
        "text": "list then we know we are learning",
        "start": 885.56,
        "duration": 4.92
    },
    {
        "text": "correctly and so basically the the AI",
        "start": 887.48,
        "duration": 5.799
    },
    {
        "text": "can automatically learn some features to",
        "start": 890.48,
        "duration": 5.32
    },
    {
        "text": "tell animals apart from the other",
        "start": 893.279,
        "duration": 4.961
    },
    {
        "text": "without ahead of time individually",
        "start": 895.8,
        "duration": 4.56
    },
    {
        "text": "labeled pictures right so this is kind",
        "start": 898.24,
        "duration": 3.92
    },
    {
        "text": "of denovo learning you don't really need",
        "start": 900.36,
        "duration": 4.52
    },
    {
        "text": "labeled pictures which is pretty nifty",
        "start": 902.16,
        "duration": 6.32
    },
    {
        "text": "and so in our case every tumor is a",
        "start": 904.88,
        "duration": 6.28
    },
    {
        "text": "zoo and in each tumor you have many",
        "start": 908.48,
        "duration": 5.2
    },
    {
        "text": "antigens it's like every Zoo have many",
        "start": 911.16,
        "duration": 5.28
    },
    {
        "text": "many different animals and in each tumor",
        "start": 913.68,
        "duration": 4.12
    },
    {
        "text": "we also",
        "start": 916.44,
        "duration": 3.8
    },
    {
        "text": "computationally extracted many many",
        "start": 917.8,
        "duration": 4.32
    },
    {
        "text": "antibodies and they are like the",
        "start": 920.24,
        "duration": 5.08
    },
    {
        "text": "pictures in that zoo and so we know that",
        "start": 922.12,
        "duration": 6.719
    },
    {
        "text": "uh within each tumor the antibodies are",
        "start": 925.32,
        "duration": 6.24
    },
    {
        "text": "to only recognize the antigens in that",
        "start": 928.839,
        "duration": 5.48
    },
    {
        "text": "tumor um and so if I have only one tumor",
        "start": 931.56,
        "duration": 4.6
    },
    {
        "text": "I can't tell how to match them but if I",
        "start": 934.319,
        "duration": 3.44
    },
    {
        "text": "have so many different tumors and they",
        "start": 936.16,
        "duration": 3.88
    },
    {
        "text": "are all different I can do the same",
        "start": 937.759,
        "duration": 5.64
    },
    {
        "text": "thing the noo infer the antigen antibody",
        "start": 940.04,
        "duration": 7.56
    },
    {
        "text": "pairs without uh knowing you a database",
        "start": 943.399,
        "duration": 7.8
    },
    {
        "text": "of antigen and antibody in a database so",
        "start": 947.6,
        "duration": 5.479
    },
    {
        "text": "the basic idea is that when you see a",
        "start": 951.199,
        "duration": 5.08
    },
    {
        "text": "Target being present in the tumor do we",
        "start": 953.079,
        "duration": 6.081
    },
    {
        "text": "see some antibody sequence features",
        "start": 956.279,
        "duration": 5.401
    },
    {
        "text": "that repeatedly are associated with this",
        "start": 959.16,
        "duration": 4.96
    },
    {
        "text": "Target and they are absent in the tumor",
        "start": 961.68,
        "duration": 5.399
    },
    {
        "text": "that don't have this target right so um",
        "start": 964.12,
        "duration": 4.719
    },
    {
        "text": "the nice thing there is we are not",
        "start": 967.079,
        "duration": 3.961
    },
    {
        "text": "asking the whole antibody sequence to be",
        "start": 968.839,
        "duration": 5.201
    },
    {
        "text": "identical in all the patients because um",
        "start": 971.04,
        "duration": 4.76
    },
    {
        "text": "when antibody sequence could be pretty",
        "start": 974.04,
        "duration": 3.88
    },
    {
        "text": "long the actual binding sequence is",
        "start": 975.8,
        "duration": 5.159
    },
    {
        "text": "called paratope they could be just six",
        "start": 977.92,
        "duration": 6.039
    },
    {
        "text": "or eight amino acid long and there could",
        "start": 980.959,
        "duration": 6.0
    },
    {
        "text": "even be short patches with a gap in the",
        "start": 983.959,
        "duration": 5.761
    },
    {
        "text": "middle the AI can automatically figure",
        "start": 986.959,
        "duration": 4.481
    },
    {
        "text": "this out you know what are the important",
        "start": 989.72,
        "duration": 4.039
    },
    {
        "text": "features that are repeatedly appearing",
        "start": 991.44,
        "duration": 4.92
    },
    {
        "text": "with that Target in the patient tumors",
        "start": 993.759,
        "duration": 4.161
    },
    {
        "text": "and that's kind of the beauty of this",
        "start": 996.36,
        "duration": 3.76
    },
    {
        "text": "it's it's like a you are not asking the",
        "start": 997.92,
        "duration": 4.039
    },
    {
        "text": "whole tiger to look the same instead",
        "start": 1000.12,
        "duration": 3.92
    },
    {
        "text": "you're looking at some you know patch on",
        "start": 1001.959,
        "duration": 4.24
    },
    {
        "text": "eye on on the skin and on the nose then",
        "start": 1004.04,
        "duration": 4.279
    },
    {
        "text": "you know oh this is a tiger right so we",
        "start": 1006.199,
        "duration": 5.2
    },
    {
        "text": "are doing kind of the same thing here um",
        "start": 1008.319,
        "duration": 6.041
    },
    {
        "text": "and so another interesting thing is when",
        "start": 1011.399,
        "duration": 5.641
    },
    {
        "text": "we see an antigen in the tumor and if",
        "start": 1014.36,
        "duration": 4.52
    },
    {
        "text": "many many patients repeat repeatedly",
        "start": 1017.04,
        "duration": 4.479
    },
    {
        "text": "make antibody against that Target it",
        "start": 1018.88,
        "duration": 4.199
    },
    {
        "text": "would tell us that this target is",
        "start": 1021.519,
        "duration": 4.28
    },
    {
        "text": "potentially a good cancer drug Target",
        "start": 1023.079,
        "duration": 4.72
    },
    {
        "text": "and antibodies that we already saw in",
        "start": 1025.799,
        "duration": 3.841
    },
    {
        "text": "the patient tumors are potential good",
        "start": 1027.799,
        "duration": 5.361
    },
    {
        "text": "drugs that we can develop into antibody",
        "start": 1029.64,
        "duration": 6.919
    },
    {
        "text": "Therapeutics um so an an analogy of this",
        "start": 1033.16,
        "duration": 6.36
    },
    {
        "text": "is like this um you can imagine uh in a",
        "start": 1036.559,
        "duration": 7.0
    },
    {
        "text": "zoo when a Zoo have a panda oh tourists",
        "start": 1039.52,
        "duration": 6.12
    },
    {
        "text": "love to take photos of this because it's",
        "start": 1043.559,
        "duration": 3.561
    },
    {
        "text": "really cool they share it on their",
        "start": 1045.64,
        "duration": 4.32
    },
    {
        "text": "social media so um panda is very",
        "start": 1047.12,
        "duration": 6.0
    },
    {
        "text": "photogenic whereas if the zoo has a a",
        "start": 1049.96,
        "duration": 5.16
    },
    {
        "text": "goat oh it's so boring who wants to take",
        "start": 1053.12,
        "duration": 4.559
    },
    {
        "text": "photos and you know gener like a and",
        "start": 1055.12,
        "duration": 5.16
    },
    {
        "text": "share it on a social media then it's not",
        "start": 1057.679,
        "duration": 5.0
    },
    {
        "text": "as good a Target and So based on the",
        "start": 1060.28,
        "duration": 4.56
    },
    {
        "text": "pictures we can tell which Target is or",
        "start": 1062.679,
        "duration": 4.161
    },
    {
        "text": "the antibodies we can tell which Target",
        "start": 1064.84,
        "duration": 2.959
    },
    {
        "text": "is more",
        "start": 1066.84,
        "duration": 4.68
    },
    {
        "text": "interesting um so so actually based on",
        "start": 1067.799,
        "duration": 5.841
    },
    {
        "text": "the antibody signals we could already",
        "start": 1071.52,
        "duration": 4.639
    },
    {
        "text": "tell pdy is a very good Target",
        "start": 1073.64,
        "duration": 4.56
    },
    {
        "text": "interestingly many many patients make a",
        "start": 1076.159,
        "duration": 3.76
    },
    {
        "text": "little little bit of pd1 antibody",
        "start": 1078.2,
        "duration": 4.0
    },
    {
        "text": "already in their tumor it's a better",
        "start": 1079.919,
        "duration": 5.401
    },
    {
        "text": "Target than pdl1 and um it's actually",
        "start": 1082.2,
        "duration": 6.04
    },
    {
        "text": "much better than T targets like cd47 and",
        "start": 1085.32,
        "duration": 6.08
    },
    {
        "text": "Sig like 15 um these two drugs you know",
        "start": 1088.24,
        "duration": 5.76
    },
    {
        "text": "were developed in the clinic um and",
        "start": 1091.4,
        "duration": 4.759
    },
    {
        "text": "showed a lot of Promise initially but we",
        "start": 1094.0,
        "duration": 3.799
    },
    {
        "text": "almost never see patients making",
        "start": 1096.159,
        "duration": 4.921
    },
    {
        "text": "antibodies against them and um",
        "start": 1097.799,
        "duration": 4.681
    },
    {
        "text": "unfortunately they're not doing well in",
        "start": 1101.08,
        "duration": 4.16
    },
    {
        "text": "the clinic right now and so um I can",
        "start": 1102.48,
        "duration": 5.16
    },
    {
        "text": "show you the pd1 result so without",
        "start": 1105.24,
        "duration": 4.6
    },
    {
        "text": "looking at any any existing pd1",
        "start": 1107.64,
        "duration": 5.08
    },
    {
        "text": "antibodies we just totally use the tumor",
        "start": 1109.84,
        "duration": 5.839
    },
    {
        "text": "profiles to help us build a denal pd1",
        "start": 1112.72,
        "duration": 6.16
    },
    {
        "text": "model and with that model basically",
        "start": 1115.679,
        "duration": 5.641
    },
    {
        "text": "after we finish AI if you feed the AI",
        "start": 1118.88,
        "duration": 5.08
    },
    {
        "text": "Model A sequence that the AI model can",
        "start": 1121.32,
        "duration": 4.28
    },
    {
        "text": "tell us whether this is going to be a",
        "start": 1123.96,
        "duration": 5.0
    },
    {
        "text": "pd1 antibody or not and so there was a",
        "start": 1125.6,
        "duration": 5.959
    },
    {
        "text": "paper published where they um",
        "start": 1128.96,
        "duration": 5.92
    },
    {
        "text": "synthesized 10 pd1 antibodies that are",
        "start": 1131.559,
        "duration": 5.201
    },
    {
        "text": "already in the",
        "start": 1134.88,
        "duration": 4.679
    },
    {
        "text": "clinic and then in visually measured the",
        "start": 1136.76,
        "duration": 4.88
    },
    {
        "text": "Affinity of these antibodies against the",
        "start": 1139.559,
        "duration": 5.041
    },
    {
        "text": "pd1 Target and so we run those 10",
        "start": 1141.64,
        "duration": 5.6
    },
    {
        "text": "sequences into this denovo derived AI",
        "start": 1144.6,
        "duration": 5.48
    },
    {
        "text": "model against pd1 and not only we can",
        "start": 1147.24,
        "duration": 5.08
    },
    {
        "text": "predict that they are pd1 antibodies but",
        "start": 1150.08,
        "duration": 5.24
    },
    {
        "text": "also um our predicted Affinity",
        "start": 1152.32,
        "duration": 6.32
    },
    {
        "text": "surprising to us even uh correlated with",
        "start": 1155.32,
        "duration": 6.359
    },
    {
        "text": "the measured pd1 Affinity so the early",
        "start": 1158.64,
        "duration": 5.519
    },
    {
        "text": "pd1 antibodies developed by Merk and",
        "start": 1161.679,
        "duration": 4.801
    },
    {
        "text": "burst Myer scrip they actually have",
        "start": 1164.159,
        "duration": 5.321
    },
    {
        "text": "pretty low Affinity the later antibodies",
        "start": 1166.48,
        "duration": 6.0
    },
    {
        "text": "developed by Novartis and also Beijing",
        "start": 1169.48,
        "duration": 5.199
    },
    {
        "text": "um they have higher Affinity which is",
        "start": 1172.48,
        "duration": 4.36
    },
    {
        "text": "not surprising you know a lot of times",
        "start": 1174.679,
        "duration": 3.88
    },
    {
        "text": "and the later companies just they just",
        "start": 1176.84,
        "duration": 3.4
    },
    {
        "text": "do this they say okay there is a pd1",
        "start": 1178.559,
        "duration": 4.521
    },
    {
        "text": "antibody from Merc against the pd1 let's",
        "start": 1180.24,
        "duration": 4.64
    },
    {
        "text": "develop another antibody that can kind",
        "start": 1183.08,
        "duration": 4.88
    },
    {
        "text": "of squeeze out the Puda antibody then it",
        "start": 1184.88,
        "duration": 5.48
    },
    {
        "text": "certainly would have a higher affinity",
        "start": 1187.96,
        "duration": 6.04
    },
    {
        "text": "and so um we ask can can we use AI to",
        "start": 1190.36,
        "duration": 5.88
    },
    {
        "text": "generate another antibody this is by the",
        "start": 1194.0,
        "duration": 4.72
    },
    {
        "text": "way it's not really a generative model",
        "start": 1196.24,
        "duration": 4.36
    },
    {
        "text": "um we are just pulling out antibod that",
        "start": 1198.72,
        "duration": 3.4
    },
    {
        "text": "are already present in the patient",
        "start": 1200.6,
        "duration": 4.48
    },
    {
        "text": "tumors and so then we tested them indeed",
        "start": 1202.12,
        "duration": 6.0
    },
    {
        "text": "they bind but interestingly um it it",
        "start": 1205.08,
        "duration": 5.2
    },
    {
        "text": "binds with very high Affinity but it's a",
        "start": 1208.12,
        "duration": 4.0
    },
    {
        "text": "different epitope with Kuda They Don't",
        "start": 1210.28,
        "duration": 4.279
    },
    {
        "text": "Really compete with Kuda but we know it",
        "start": 1212.12,
        "duration": 6.0
    },
    {
        "text": "can fully block a pd1 PD interaction and",
        "start": 1214.559,
        "duration": 5.681
    },
    {
        "text": "so when we tested this in in Mouse",
        "start": 1218.12,
        "duration": 5.4
    },
    {
        "text": "tumors so Mouse and human have different",
        "start": 1220.24,
        "duration": 5.96
    },
    {
        "text": "pd1 sequence and the functional domain",
        "start": 1223.52,
        "duration": 4.399
    },
    {
        "text": "is different so we have to get a mouse",
        "start": 1226.2,
        "duration": 4.52
    },
    {
        "text": "that Express a human pd1 to test our",
        "start": 1227.919,
        "duration": 6.601
    },
    {
        "text": "antibody and the Kuda antibody um and",
        "start": 1230.72,
        "duration": 5.48
    },
    {
        "text": "you can see that um our antibody",
        "start": 1234.52,
        "duration": 4.279
    },
    {
        "text": "actually even worked better than the",
        "start": 1236.2,
        "duration": 5.52
    },
    {
        "text": "Kuda antibody in terms of tumor control",
        "start": 1238.799,
        "duration": 4.601
    },
    {
        "text": "of course we're not developing this",
        "start": 1241.72,
        "duration": 3.8
    },
    {
        "text": "antibody because Kuda antibody will be",
        "start": 1243.4,
        "duration": 4.56
    },
    {
        "text": "out of patent in two to three years and",
        "start": 1245.52,
        "duration": 4.84
    },
    {
        "text": "so this just serve as a proof of",
        "start": 1247.96,
        "duration": 4.719
    },
    {
        "text": "concept and so with this we we kind of",
        "start": 1250.36,
        "duration": 4.88
    },
    {
        "text": "gain more confidence we ask okay can we",
        "start": 1252.679,
        "duration": 4.681
    },
    {
        "text": "get other antibod you know we tried can",
        "start": 1255.24,
        "duration": 4.88
    },
    {
        "text": "we get EG antibodies yes patient make",
        "start": 1257.36,
        "duration": 5.559
    },
    {
        "text": "egfr can we get her to antibodies Yes",
        "start": 1260.12,
        "duration": 4.4
    },
    {
        "text": "actually there is a both load of her two",
        "start": 1262.919,
        "duration": 3.721
    },
    {
        "text": "antibodies and patient tumors we also",
        "start": 1264.52,
        "duration": 6.32
    },
    {
        "text": "tried other um either um like pretty hot",
        "start": 1266.64,
        "duration": 6.96
    },
    {
        "text": "Targets in immune oncology or um",
        "start": 1270.84,
        "duration": 5.88
    },
    {
        "text": "oncology like ADC targets and in each of",
        "start": 1273.6,
        "duration": 6.0
    },
    {
        "text": "them um we we were able to use AI to",
        "start": 1276.72,
        "duration": 5.4
    },
    {
        "text": "pull out antibodies from patient tumors",
        "start": 1279.6,
        "duration": 4.559
    },
    {
        "text": "that we then validated indeed bind to",
        "start": 1282.12,
        "duration": 4.4
    },
    {
        "text": "the Target of interest and some of them",
        "start": 1284.159,
        "duration": 4.721
    },
    {
        "text": "have very very interesting property",
        "start": 1286.52,
        "duration": 4.96
    },
    {
        "text": "um so for example you know the B7 H3",
        "start": 1288.88,
        "duration": 4.679
    },
    {
        "text": "Target is actually very conserved",
        "start": 1291.48,
        "duration": 4.4
    },
    {
        "text": "between human and mouse and if you were",
        "start": 1293.559,
        "duration": 5.681
    },
    {
        "text": "to use this target as a antigen to",
        "start": 1295.88,
        "duration": 6.76
    },
    {
        "text": "immunize the Mouse um at the end most of",
        "start": 1299.24,
        "duration": 5.6
    },
    {
        "text": "the antibodies generated are only",
        "start": 1302.64,
        "duration": 3.8
    },
    {
        "text": "against the region that's different",
        "start": 1304.84,
        "duration": 3.839
    },
    {
        "text": "between human mouthe whereas you know",
        "start": 1306.44,
        "duration": 4.479
    },
    {
        "text": "when we get this antibody it actually",
        "start": 1308.679,
        "duration": 4.321
    },
    {
        "text": "crossreact to both human and mouse which",
        "start": 1310.919,
        "duration": 4.601
    },
    {
        "text": "is great and there are also other antib",
        "start": 1313.0,
        "duration": 5.76
    },
    {
        "text": "like this one against netive four the",
        "start": 1315.52,
        "duration": 5.72
    },
    {
        "text": "initial AI predicted antibody we found",
        "start": 1318.76,
        "duration": 5.0
    },
    {
        "text": "can preferentially bind to NE four in",
        "start": 1321.24,
        "duration": 5.679
    },
    {
        "text": "acidic environment we hypothesize that",
        "start": 1323.76,
        "duration": 6.159
    },
    {
        "text": "in the tumors it's actually already very",
        "start": 1326.919,
        "duration": 5.681
    },
    {
        "text": "acidic because of hypoxia so the tumor",
        "start": 1329.919,
        "duration": 4.801
    },
    {
        "text": "is actually more acidic and so the",
        "start": 1332.6,
        "duration": 4.24
    },
    {
        "text": "antibodies that are generated under the",
        "start": 1334.72,
        "duration": 4.959
    },
    {
        "text": "natural environment just bind to the",
        "start": 1336.84,
        "duration": 5.88
    },
    {
        "text": "acidic form in a higher Affinity than",
        "start": 1339.679,
        "duration": 5.841
    },
    {
        "text": "the neutral form so we feel like because",
        "start": 1342.72,
        "duration": 5.68
    },
    {
        "text": "we're deriving this antibody directly",
        "start": 1345.52,
        "duration": 5.159
    },
    {
        "text": "from patient tumors they they kind of",
        "start": 1348.4,
        "duration": 5.879
    },
    {
        "text": "have all these tumor properties as well",
        "start": 1350.679,
        "duration": 6.721
    },
    {
        "text": "um and so here is the way we kind of use",
        "start": 1354.279,
        "duration": 5.441
    },
    {
        "text": "the platform for our drug Discovery",
        "start": 1357.4,
        "duration": 6.04
    },
    {
        "text": "effort um again we call this platform",
        "start": 1359.72,
        "duration": 6.24
    },
    {
        "text": "simultaneous Target evaluation and",
        "start": 1363.44,
        "duration": 5.92
    },
    {
        "text": "antibody Discovery because most AI drug",
        "start": 1365.96,
        "duration": 7.44
    },
    {
        "text": "Discovery companies they need to um use",
        "start": 1369.36,
        "duration": 6.24
    },
    {
        "text": "either published literature or farmer",
        "start": 1373.4,
        "duration": 5.24
    },
    {
        "text": "partnership to nominate a Target and the",
        "start": 1375.6,
        "duration": 5.079
    },
    {
        "text": "function of the target needs to be fully",
        "start": 1378.64,
        "duration": 4.159
    },
    {
        "text": "understood before they can use AI to",
        "start": 1380.679,
        "duration": 4.721
    },
    {
        "text": "develop drugs but in our case we kind of",
        "start": 1382.799,
        "duration": 5.441
    },
    {
        "text": "don't do it this way we are using 40,000",
        "start": 1385.4,
        "duration": 5.92
    },
    {
        "text": "cancer patients as our ex experimental",
        "start": 1388.24,
        "duration": 5.2
    },
    {
        "text": "system and we know that they're all",
        "start": 1391.32,
        "duration": 4.2
    },
    {
        "text": "trying right to cure the tumor they just",
        "start": 1393.44,
        "duration": 4.599
    },
    {
        "text": "failed but we at least we can see what",
        "start": 1395.52,
        "duration": 4.519
    },
    {
        "text": "kind of battle do they fight and if",
        "start": 1398.039,
        "duration": 4.041
    },
    {
        "text": "there are some local battles that are",
        "start": 1400.039,
        "duration": 4.481
    },
    {
        "text": "repeatedly fought by many many patients",
        "start": 1402.08,
        "duration": 4.56
    },
    {
        "text": "maybe that's a good battle and So based",
        "start": 1404.52,
        "duration": 3.88
    },
    {
        "text": "on the tumor profile and the",
        "start": 1406.64,
        "duration": 4.68
    },
    {
        "text": "AI antibody matching to the Target we",
        "start": 1408.4,
        "duration": 5.12
    },
    {
        "text": "can already kind of rank you know which",
        "start": 1411.32,
        "duration": 4.44
    },
    {
        "text": "is Panda which is goat in in terms of",
        "start": 1413.52,
        "duration": 5.039
    },
    {
        "text": "cancer Target and each of them we can we",
        "start": 1415.76,
        "duration": 4.48
    },
    {
        "text": "use AI to predict which are the",
        "start": 1418.559,
        "duration": 3.401
    },
    {
        "text": "corresponding antibodies against the",
        "start": 1420.24,
        "duration": 3.799
    },
    {
        "text": "target of Interest so that's kind of our",
        "start": 1421.96,
        "duration": 4.48
    },
    {
        "text": "initial ranking of which thing are",
        "start": 1424.039,
        "duration": 5.041
    },
    {
        "text": "interesting and the second step is",
        "start": 1426.44,
        "duration": 4.88
    },
    {
        "text": "really prioritization remember we",
        "start": 1429.08,
        "duration": 4.24
    },
    {
        "text": "started the company as a crisper screen",
        "start": 1431.32,
        "duration": 4.16
    },
    {
        "text": "company so in the first three years we",
        "start": 1433.32,
        "duration": 4.839
    },
    {
        "text": "did like all like many many immune Rel",
        "start": 1435.48,
        "duration": 4.76
    },
    {
        "text": "crisper Queens we just knock out each",
        "start": 1438.159,
        "duration": 5.281
    },
    {
        "text": "gene in turn in a Cell population and",
        "start": 1440.24,
        "duration": 5.64
    },
    {
        "text": "then see which Gene knockout give us the",
        "start": 1443.44,
        "duration": 5.56
    },
    {
        "text": "phenotype say tumor growth or uh cell",
        "start": 1445.88,
        "duration": 5.44
    },
    {
        "text": "surface protein expression and so on we",
        "start": 1449.0,
        "duration": 4.279
    },
    {
        "text": "also collected a lot of public uh",
        "start": 1451.32,
        "duration": 3.959
    },
    {
        "text": "crisper screens and we really ask you",
        "start": 1453.279,
        "duration": 3.88
    },
    {
        "text": "know which Gene knockout give us an",
        "start": 1455.279,
        "duration": 5.081
    },
    {
        "text": "interesting um phenotype um the rest is",
        "start": 1457.159,
        "duration": 5.721
    },
    {
        "text": "just more public data mining we look at",
        "start": 1460.36,
        "duration": 5.28
    },
    {
        "text": "the normal tissues cancer cell lines",
        "start": 1462.88,
        "duration": 5.64
    },
    {
        "text": "mouth tumors and uh human tumor",
        "start": 1465.64,
        "duration": 6.159
    },
    {
        "text": "and to look at DNA RNA epigenetics",
        "start": 1468.52,
        "duration": 5.2
    },
    {
        "text": "proteomics data some single cell data",
        "start": 1471.799,
        "duration": 4.0
    },
    {
        "text": "and also very limited immunotherapy",
        "start": 1473.72,
        "duration": 4.439
    },
    {
        "text": "trial samples to help us generate",
        "start": 1475.799,
        "duration": 5.161
    },
    {
        "text": "hypothesis is this Gene expressed on",
        "start": 1478.159,
        "duration": 5.081
    },
    {
        "text": "cancer cells or immune cells is it",
        "start": 1480.96,
        "duration": 5.0
    },
    {
        "text": "associated with some immune signal is it",
        "start": 1483.24,
        "duration": 4.799
    },
    {
        "text": "uh influencing patient survival or",
        "start": 1485.96,
        "duration": 4.04
    },
    {
        "text": "immunotherapy response right so with",
        "start": 1488.039,
        "duration": 4.76
    },
    {
        "text": "these um crisper Queen and public data",
        "start": 1490.0,
        "duration": 5.36
    },
    {
        "text": "to help us prioritize we then go to the",
        "start": 1492.799,
        "duration": 5.201
    },
    {
        "text": "experimental validation ask um you know",
        "start": 1495.36,
        "duration": 4.6
    },
    {
        "text": "if the AI predicted antibody indeed",
        "start": 1498.0,
        "duration": 3.96
    },
    {
        "text": "buying to the Target of interest and",
        "start": 1499.96,
        "duration": 5.04
    },
    {
        "text": "then invidual or invivo characterize the",
        "start": 1501.96,
        "duration": 5.56
    },
    {
        "text": "the antibody and uh that's how we came",
        "start": 1505.0,
        "duration": 4.12
    },
    {
        "text": "to the lead",
        "start": 1507.52,
        "duration": 4.0
    },
    {
        "text": "program and so in terms of you know",
        "start": 1509.12,
        "duration": 5.279
    },
    {
        "text": "other AI especially AI antibody",
        "start": 1511.52,
        "duration": 4.56
    },
    {
        "text": "Discovery companies there are many",
        "start": 1514.399,
        "duration": 5.201
    },
    {
        "text": "companies recently um some of them um",
        "start": 1516.08,
        "duration": 5.079
    },
    {
        "text": "they they don't come up with novel",
        "start": 1519.6,
        "duration": 4.439
    },
    {
        "text": "Target also many of them will require a",
        "start": 1521.159,
        "duration": 5.4
    },
    {
        "text": "know antibody against a Target already",
        "start": 1524.039,
        "duration": 4.36
    },
    {
        "text": "so if you already know this antibody",
        "start": 1526.559,
        "duration": 4.041
    },
    {
        "text": "binds to this Target and then you can",
        "start": 1528.399,
        "duration": 4.041
    },
    {
        "text": "experimentally generate a lot of",
        "start": 1530.6,
        "duration": 4.079
    },
    {
        "text": "slightly different sequences and you can",
        "start": 1532.44,
        "duration": 4.16
    },
    {
        "text": "test whether that makes the antibody",
        "start": 1534.679,
        "duration": 4.12
    },
    {
        "text": "bind stronger or weaker and with enough",
        "start": 1536.6,
        "duration": 5.24
    },
    {
        "text": "data you can build AI models to get a",
        "start": 1538.799,
        "duration": 5.161
    },
    {
        "text": "even better antibody for us that's kind",
        "start": 1541.84,
        "duration": 4.92
    },
    {
        "text": "of a pretty simple easy question right",
        "start": 1543.96,
        "duration": 4.92
    },
    {
        "text": "um there are also two companies they are",
        "start": 1546.76,
        "duration": 4.639
    },
    {
        "text": "getting antibodies from patient tumors",
        "start": 1548.88,
        "duration": 4.88
    },
    {
        "text": "but they are sequencing the tumors",
        "start": 1551.399,
        "duration": 4.681
    },
    {
        "text": "themselves and so from like a dozen",
        "start": 1553.76,
        "duration": 4.159
    },
    {
        "text": "patients here and there and they're",
        "start": 1556.08,
        "duration": 4.479
    },
    {
        "text": "asking the full antibody to repeatedly",
        "start": 1557.919,
        "duration": 4.961
    },
    {
        "text": "appear in two patients or three patients",
        "start": 1560.559,
        "duration": 4.641
    },
    {
        "text": "it's much much harder and then once they",
        "start": 1562.88,
        "duration": 4.56
    },
    {
        "text": "have an antibody they test it on a",
        "start": 1565.2,
        "duration": 4.599
    },
    {
        "text": "protein array with all like 10,000",
        "start": 1567.44,
        "duration": 4.88
    },
    {
        "text": "different antigens to see where this",
        "start": 1569.799,
        "duration": 4.841
    },
    {
        "text": "antibody might bind which is pretty",
        "start": 1572.32,
        "duration": 5.719
    },
    {
        "text": "cumbersome especially say if you get one",
        "start": 1574.64,
        "duration": 6.68
    },
    {
        "text": "herle antibody and it has some issues",
        "start": 1578.039,
        "duration": 4.961
    },
    {
        "text": "you you say oh give me another her to",
        "start": 1581.32,
        "duration": 4.04
    },
    {
        "text": "antibody it will take the many many",
        "start": 1583.0,
        "duration": 4.279
    },
    {
        "text": "experimental testing to get you a second",
        "start": 1585.36,
        "duration": 3.4
    },
    {
        "text": "because every time they try a random",
        "start": 1587.279,
        "duration": 3.561
    },
    {
        "text": "antibody they hope it's a hurt tool",
        "start": 1588.76,
        "duration": 4.72
    },
    {
        "text": "right it's not easy but in our case we",
        "start": 1590.84,
        "duration": 6.04
    },
    {
        "text": "start from many many patient samples um",
        "start": 1593.48,
        "duration": 5.6
    },
    {
        "text": "and we use AI to already say okay this",
        "start": 1596.88,
        "duration": 4.32
    },
    {
        "text": "target is potentially interesting and",
        "start": 1599.08,
        "duration": 3.76
    },
    {
        "text": "every time when we make prediction we",
        "start": 1601.2,
        "duration": 3.44
    },
    {
        "text": "predict many antibody against that",
        "start": 1602.84,
        "duration": 4.28
    },
    {
        "text": "Target at the same time another thing we",
        "start": 1604.64,
        "duration": 5.36
    },
    {
        "text": "found is that if this paratope is really",
        "start": 1607.12,
        "duration": 6.24
    },
    {
        "text": "repeatedly appearing in so many patients",
        "start": 1610.0,
        "duration": 5.76
    },
    {
        "text": "um it seem to be enriched in functional",
        "start": 1613.36,
        "duration": 4.439
    },
    {
        "text": "binding you know the say on the PD one",
        "start": 1615.76,
        "duration": 3.96
    },
    {
        "text": "there are many many different locations",
        "start": 1617.799,
        "duration": 4.48
    },
    {
        "text": "you combine but the function of antibody",
        "start": 1619.72,
        "duration": 6.0
    },
    {
        "text": "can really block pd1 pdy interaction if",
        "start": 1622.279,
        "duration": 5.561
    },
    {
        "text": "this thing is functional then that",
        "start": 1625.72,
        "duration": 4.36
    },
    {
        "text": "antibodies production will stimulate",
        "start": 1627.84,
        "duration": 4.559
    },
    {
        "text": "some local cyto kindes allowing this",
        "start": 1630.08,
        "duration": 5.44
    },
    {
        "text": "little b cell to expand even more or",
        "start": 1632.399,
        "duration": 5.4
    },
    {
        "text": "also repeatedly in different patients",
        "start": 1635.52,
        "duration": 3.96
    },
    {
        "text": "and therefore using this approach we",
        "start": 1637.799,
        "duration": 4.041
    },
    {
        "text": "seem to be enriching for functional",
        "start": 1639.48,
        "duration": 5.64
    },
    {
        "text": "antibodies um another thing is um when",
        "start": 1641.84,
        "duration": 6.52
    },
    {
        "text": "you generate like purely generate a",
        "start": 1645.12,
        "duration": 6.52
    },
    {
        "text": "antibodies um it's not natural to human",
        "start": 1648.36,
        "duration": 4.559
    },
    {
        "text": "therefore when you give it to the",
        "start": 1651.64,
        "duration": 3.32
    },
    {
        "text": "patient the patient can actually",
        "start": 1652.919,
        "duration": 4.961
    },
    {
        "text": "generate antibody against your drug and",
        "start": 1654.96,
        "duration": 5.04
    },
    {
        "text": "then the the the anti your drug antibody",
        "start": 1657.88,
        "duration": 5.24
    },
    {
        "text": "will no longer be um active um because",
        "start": 1660.0,
        "duration": 5.44
    },
    {
        "text": "the antibody we get are from patient",
        "start": 1663.12,
        "duration": 4.799
    },
    {
        "text": "already they are 100% natural like it's",
        "start": 1665.44,
        "duration": 5.04
    },
    {
        "text": "fully human therefore we believe that um",
        "start": 1667.919,
        "duration": 4.76
    },
    {
        "text": "it will unlikely to be rejected by",
        "start": 1670.48,
        "duration": 5.0
    },
    {
        "text": "humans and we also already have a clinic",
        "start": 1672.679,
        "duration": 6.081
    },
    {
        "text": "already already a molecule in the clinic",
        "start": 1675.48,
        "duration": 5.039
    },
    {
        "text": "compared to other companies who are just",
        "start": 1678.76,
        "duration": 4.6
    },
    {
        "text": "providing service to other",
        "start": 1680.519,
        "duration": 6.441
    },
    {
        "text": "Pharma so um this kind of ends the",
        "start": 1683.36,
        "duration": 5.96
    },
    {
        "text": "platform part of the talk and I will now",
        "start": 1686.96,
        "duration": 5.16
    },
    {
        "text": "explain the lead program that we are",
        "start": 1689.32,
        "duration": 6.12
    },
    {
        "text": "developing um so this is a uh novel",
        "start": 1692.12,
        "duration": 5.799
    },
    {
        "text": "Target that we discovered at a company",
        "start": 1695.44,
        "duration": 3.599
    },
    {
        "text": "um called",
        "start": 1697.919,
        "duration": 4.041
    },
    {
        "text": "igsf8 and so the the way we discovered",
        "start": 1699.039,
        "duration": 5.561
    },
    {
        "text": "this is we were asking oh if pd1 is good",
        "start": 1701.96,
        "duration": 4.439
    },
    {
        "text": "and it's better than pdl1 and other",
        "start": 1704.6,
        "duration": 4.36
    },
    {
        "text": "targets are there are some similar",
        "start": 1706.399,
        "duration": 4.28
    },
    {
        "text": "things like a pd1 there are like a",
        "start": 1708.96,
        "duration": 5.0
    },
    {
        "text": "pandas in in the tumors um many many",
        "start": 1710.679,
        "duration": 4.84
    },
    {
        "text": "patients make a little bit of this",
        "start": 1713.96,
        "duration": 4.4
    },
    {
        "text": "antibody and yet it has very little",
        "start": 1715.519,
        "duration": 4.88
    },
    {
        "text": "pattern coverage so for each Target we",
        "start": 1718.36,
        "duration": 4.159
    },
    {
        "text": "check how many antibodies have people",
        "start": 1720.399,
        "duration": 4.361
    },
    {
        "text": "filed pattern against this Target and",
        "start": 1722.519,
        "duration": 5.0
    },
    {
        "text": "this one is like empty nothing available",
        "start": 1724.76,
        "duration": 5.279
    },
    {
        "text": "so it was kind of interesting and um",
        "start": 1727.519,
        "duration": 5.721
    },
    {
        "text": "igsf stands for immunoglobin super",
        "start": 1730.039,
        "duration": 5.281
    },
    {
        "text": "family it's a big family of proteins on",
        "start": 1733.24,
        "duration": 5.159
    },
    {
        "text": "the cell surface and all the current",
        "start": 1735.32,
        "duration": 6.359
    },
    {
        "text": "immune checkpoint uh molecules are",
        "start": 1738.399,
        "duration": 7.241
    },
    {
        "text": "targeting igsf like pd1 pdl1 ctl4 they",
        "start": 1741.679,
        "duration": 7.401
    },
    {
        "text": "all belong to igsf family so we ask um",
        "start": 1745.64,
        "duration": 5.759
    },
    {
        "text": "are there other molecules like this um",
        "start": 1749.08,
        "duration": 4.52
    },
    {
        "text": "because igsf family are known to mediate",
        "start": 1751.399,
        "duration": 4.841
    },
    {
        "text": "cell cell interactions and so we saw",
        "start": 1753.6,
        "duration": 4.04
    },
    {
        "text": "this Gene you know having pretty good",
        "start": 1756.24,
        "duration": 4.159
    },
    {
        "text": "antibody signals then we ask how about",
        "start": 1757.64,
        "duration": 4.279
    },
    {
        "text": "crisper screens right we have some",
        "start": 1760.399,
        "duration": 3.12
    },
    {
        "text": "in-house crisper screens and there's",
        "start": 1761.919,
        "duration": 4.081
    },
    {
        "text": "public crisper screen at the time the",
        "start": 1763.519,
        "duration": 4.28
    },
    {
        "text": "broad Institute has just generated",
        "start": 1766.0,
        "duration": 3.6
    },
    {
        "text": "crisper screens on hundreds of cancer",
        "start": 1767.799,
        "duration": 4.24
    },
    {
        "text": "cell lines and we saw that normally",
        "start": 1769.6,
        "duration": 4.679
    },
    {
        "text": "knocking out this Gene does not regulate",
        "start": 1772.039,
        "duration": 5.76
    },
    {
        "text": "cell growth cells are fine unless the",
        "start": 1774.279,
        "duration": 5.52
    },
    {
        "text": "cancer cell is under immune pressure so",
        "start": 1777.799,
        "duration": 4.521
    },
    {
        "text": "we have some in-house data to show that",
        "start": 1779.799,
        "duration": 4.441
    },
    {
        "text": "even though it doesn't normally regulate",
        "start": 1782.32,
        "duration": 4.44
    },
    {
        "text": "cell growth you know outside the body",
        "start": 1784.24,
        "duration": 4.48
    },
    {
        "text": "once you implant this cancer cell into",
        "start": 1786.76,
        "duration": 4.399
    },
    {
        "text": "the mouth uh this is a fully immune",
        "start": 1788.72,
        "duration": 4.92
    },
    {
        "text": "competent Mouse um then knocking out",
        "start": 1791.159,
        "duration": 4.161
    },
    {
        "text": "this Gene will make the tumor grow",
        "start": 1793.64,
        "duration": 4.039
    },
    {
        "text": "slower um another experiment is a",
        "start": 1795.32,
        "duration": 4.44
    },
    {
        "text": "co-culture experiment we knock out",
        "start": 1797.679,
        "duration": 3.921
    },
    {
        "text": "different genes in in cancer cells and",
        "start": 1799.76,
        "duration": 3.68
    },
    {
        "text": "co-culture the cancer cell with enk",
        "start": 1801.6,
        "duration": 4.319
    },
    {
        "text": "cells natural killer cells again we saw",
        "start": 1803.44,
        "duration": 3.92
    },
    {
        "text": "that knocking out this Gene makes the",
        "start": 1805.919,
        "duration": 3.721
    },
    {
        "text": "enk cells kill the cancer cell much much",
        "start": 1807.36,
        "duration": 4.76
    },
    {
        "text": "better so we saw oh this might be a",
        "start": 1809.64,
        "duration": 3.879
    },
    {
        "text": "immune related",
        "start": 1812.12,
        "duration": 3.6
    },
    {
        "text": "molecule um and then we look at some",
        "start": 1813.519,
        "duration": 6.121
    },
    {
        "text": "public data on this and this is tcga uh",
        "start": 1815.72,
        "duration": 7.52
    },
    {
        "text": "blue is normal orange is tumor and so",
        "start": 1819.64,
        "duration": 6.12
    },
    {
        "text": "you can see um this Gene is highly",
        "start": 1823.24,
        "duration": 5.08
    },
    {
        "text": "expressed in many many solid tumors",
        "start": 1825.76,
        "duration": 5.48
    },
    {
        "text": "compared to the normal um on the right",
        "start": 1828.32,
        "duration": 5.44
    },
    {
        "text": "in the middle panel here are cancer",
        "start": 1831.24,
        "duration": 5.2
    },
    {
        "text": "types where tcj has less than 10 uh",
        "start": 1833.76,
        "duration": 4.159
    },
    {
        "text": "normal samples so you can't really",
        "start": 1836.44,
        "duration": 3.359
    },
    {
        "text": "calculate a good differential expression",
        "start": 1837.919,
        "duration": 4.281
    },
    {
        "text": "so we only look at the tumor it's also",
        "start": 1839.799,
        "duration": 4.161
    },
    {
        "text": "pretty highly expressed especially",
        "start": 1842.2,
        "duration": 3.76
    },
    {
        "text": "highest expressed in",
        "start": 1843.96,
        "duration": 4.559
    },
    {
        "text": "melanoma on the right side there are two",
        "start": 1845.96,
        "duration": 5.52
    },
    {
        "text": "cancer types where igsf8 is expressed",
        "start": 1848.519,
        "duration": 4.961
    },
    {
        "text": "the lower in the tumor compared to the",
        "start": 1851.48,
        "duration": 4.24
    },
    {
        "text": "normal and both of them are kidney",
        "start": 1853.48,
        "duration": 4.52
    },
    {
        "text": "cancers so if you work on cancer",
        "start": 1855.72,
        "duration": 4.439
    },
    {
        "text": "Immunology or immunotherapy you would",
        "start": 1858.0,
        "duration": 5.279
    },
    {
        "text": "know kidney cancers are somehow always",
        "start": 1860.159,
        "duration": 5.681
    },
    {
        "text": "different from other solid tumors in",
        "start": 1863.279,
        "duration": 5.52
    },
    {
        "text": "fact the pd1 response biomarker is also",
        "start": 1865.84,
        "duration": 4.839
    },
    {
        "text": "opposite in kidney cancer compared to",
        "start": 1868.799,
        "duration": 4.401
    },
    {
        "text": "the other cancer types which is really",
        "start": 1870.679,
        "duration": 4.521
    },
    {
        "text": "strange but this kind of give us also",
        "start": 1873.2,
        "duration": 4.88
    },
    {
        "text": "more confidence that this igsf8 might be",
        "start": 1875.2,
        "duration": 3.959
    },
    {
        "text": "immune",
        "start": 1878.08,
        "duration": 3.599
    },
    {
        "text": "related uh we also look at what other",
        "start": 1879.159,
        "duration": 4.64
    },
    {
        "text": "signals are correlated with",
        "start": 1881.679,
        "duration": 5.281
    },
    {
        "text": "igsf8 and so we see that when igsf8 is",
        "start": 1883.799,
        "duration": 3.961
    },
    {
        "text": "high",
        "start": 1886.96,
        "duration": 3.559
    },
    {
        "text": "the tumors overall have lower cd8 T Cell",
        "start": 1887.76,
        "duration": 5.6
    },
    {
        "text": "infiltration so it's a immune cold tumor",
        "start": 1890.519,
        "duration": 5.681
    },
    {
        "text": "it has lower grenzy and profence so the",
        "start": 1893.36,
        "duration": 5.72
    },
    {
        "text": "overall tumor immunity is lower it has",
        "start": 1896.2,
        "duration": 3.959
    },
    {
        "text": "lower",
        "start": 1899.08,
        "duration": 4.24
    },
    {
        "text": "pdl1 expression meaning that this tumor",
        "start": 1900.159,
        "duration": 5.841
    },
    {
        "text": "is unlikely to respond to current pd1",
        "start": 1903.32,
        "duration": 6.079
    },
    {
        "text": "pdr1 antibodies it also have very low",
        "start": 1906.0,
        "duration": 6.919
    },
    {
        "text": "b2m expression uh which is kind of low",
        "start": 1909.399,
        "duration": 6.081
    },
    {
        "text": "antigen presentation this is actually",
        "start": 1912.919,
        "duration": 5.6
    },
    {
        "text": "quite interesting and the last four",
        "start": 1915.48,
        "duration": 5.88
    },
    {
        "text": "factors are autophagy factors known to",
        "start": 1918.519,
        "duration": 6.321
    },
    {
        "text": "degrade MHC MHC class one at the protein",
        "start": 1921.36,
        "duration": 6.64
    },
    {
        "text": "level so um you know in order for for",
        "start": 1924.84,
        "duration": 5.64
    },
    {
        "text": "our our immune system or tea cells to",
        "start": 1928.0,
        "duration": 5.24
    },
    {
        "text": "recognize the cancer cell as non self",
        "start": 1930.48,
        "duration": 5.0
    },
    {
        "text": "the MHC needs to present the mutation",
        "start": 1933.24,
        "duration": 5.039
    },
    {
        "text": "onto the surface but if the protein that",
        "start": 1935.48,
        "duration": 5.159
    },
    {
        "text": "Express this gets deleted or that get",
        "start": 1938.279,
        "duration": 5.24
    },
    {
        "text": "degraded then the the mutations are",
        "start": 1940.639,
        "duration": 5.681
    },
    {
        "text": "invisible to your te- cells and so we",
        "start": 1943.519,
        "duration": 4.361
    },
    {
        "text": "can see basic",
        "start": 1946.32,
        "duration": 3.479
    },
    {
        "text": "in whenever the tumors are not",
        "start": 1947.88,
        "duration": 4.399
    },
    {
        "text": "efficiently presenting the antigens",
        "start": 1949.799,
        "duration": 6.12
    },
    {
        "text": "that's when the tumors have high IGS of8",
        "start": 1952.279,
        "duration": 6.201
    },
    {
        "text": "um in terms of survival um we we",
        "start": 1955.919,
        "duration": 5.72
    },
    {
        "text": "separated every Cancer type patient have",
        "start": 1958.48,
        "duration": 6.039
    },
    {
        "text": "have by their MHC class one High versus",
        "start": 1961.639,
        "duration": 5.76
    },
    {
        "text": "low expression and in six cancer types",
        "start": 1964.519,
        "duration": 5.4
    },
    {
        "text": "we saw that when the MHC class one is",
        "start": 1967.399,
        "duration": 6.081
    },
    {
        "text": "low high igsf8 is associated with worse",
        "start": 1969.919,
        "duration": 5.401
    },
    {
        "text": "survival so when the patient have high",
        "start": 1973.48,
        "duration": 4.52
    },
    {
        "text": "HS of8 they don't do as well",
        "start": 1975.32,
        "duration": 5.56
    },
    {
        "text": "um in other immunotherapy trials we saw",
        "start": 1978.0,
        "duration": 5.76
    },
    {
        "text": "also kind of interesting phenomenon uh",
        "start": 1980.88,
        "duration": 5.08
    },
    {
        "text": "this is a study by team chance group",
        "start": 1983.76,
        "duration": 4.08
    },
    {
        "text": "where they treated melanoma patients",
        "start": 1985.96,
        "duration": 5.28
    },
    {
        "text": "with pd1 and they are they have both",
        "start": 1987.84,
        "duration": 7.16
    },
    {
        "text": "pre-treatment and untreatment data and",
        "start": 1991.24,
        "duration": 6.439
    },
    {
        "text": "you can see the the benefit patients",
        "start": 1995.0,
        "duration": 5.0
    },
    {
        "text": "which include complete responders",
        "start": 1997.679,
        "duration": 4.761
    },
    {
        "text": "partial responders and stable disease",
        "start": 2000.0,
        "duration": 5.159
    },
    {
        "text": "patient um when they respond the tumor",
        "start": 2002.44,
        "duration": 5.32
    },
    {
        "text": "have lower IGS of8 whereas the",
        "start": 2005.159,
        "duration": 4.801
    },
    {
        "text": "nonresponders the the progressive",
        "start": 2007.76,
        "duration": 6.039
    },
    {
        "text": "disease patients um their igsf8 levels",
        "start": 2009.96,
        "duration": 6.719
    },
    {
        "text": "kind of are are kind of going everywhere",
        "start": 2013.799,
        "duration": 5.641
    },
    {
        "text": "we also saw another study by Tony rias's",
        "start": 2016.679,
        "duration": 4.96
    },
    {
        "text": "group also melanoma patient treated with",
        "start": 2019.44,
        "duration": 4.8
    },
    {
        "text": "anti pd1 even from the pre-treatment",
        "start": 2021.639,
        "duration": 4.841
    },
    {
        "text": "sample we could tell if the patient have",
        "start": 2024.24,
        "duration": 5.36
    },
    {
        "text": "lower igsf8 they are more likely to be",
        "start": 2026.48,
        "duration": 5.24
    },
    {
        "text": "uh having better response to pd1 and",
        "start": 2029.6,
        "duration": 4.84
    },
    {
        "text": "better outcome so this also give us some",
        "start": 2031.72,
        "duration": 6.36
    },
    {
        "text": "you know evidence of survival benefits",
        "start": 2034.44,
        "duration": 5.479
    },
    {
        "text": "um and so we decided to test this",
        "start": 2038.08,
        "duration": 4.92
    },
    {
        "text": "antibody predicted from Ai and we got a",
        "start": 2039.919,
        "duration": 5.36
    },
    {
        "text": "very good antibody this Gene is highly",
        "start": 2043.0,
        "duration": 4.88
    },
    {
        "text": "conserved between human and mouse 90%",
        "start": 2045.279,
        "duration": 5.4
    },
    {
        "text": "evolutionary conservation and we are",
        "start": 2047.88,
        "duration": 5.999
    },
    {
        "text": "able to uh use AI to get an antibody",
        "start": 2050.679,
        "duration": 6.48
    },
    {
        "text": "that can crossreact to um mouse rat",
        "start": 2053.879,
        "duration": 6.2
    },
    {
        "text": "monkey and human IGS of8 with similar",
        "start": 2057.159,
        "duration": 5.401
    },
    {
        "text": "Affinity so we can use the same antibody",
        "start": 2060.079,
        "duration": 5.8
    },
    {
        "text": "for animal experiments as",
        "start": 2062.56,
        "duration": 6.799
    },
    {
        "text": "well um so we tested this antibody um",
        "start": 2065.879,
        "duration": 5.841
    },
    {
        "text": "against in this case is a mouse cancer",
        "start": 2069.359,
        "duration": 5.441
    },
    {
        "text": "cell co-cultured with mouse enk cells",
        "start": 2071.72,
        "duration": 4.959
    },
    {
        "text": "and if we add the different doses of",
        "start": 2074.8,
        "duration": 4.0
    },
    {
        "text": "this antibody we can see adding this",
        "start": 2076.679,
        "duration": 4.841
    },
    {
        "text": "antibody makes the enk cells kill the",
        "start": 2078.8,
        "duration": 5.16
    },
    {
        "text": "cancer cells better so in vitro we also",
        "start": 2081.52,
        "duration": 5.119
    },
    {
        "text": "see something then we tested the animals",
        "start": 2083.96,
        "duration": 6.399
    },
    {
        "text": "inv Vivo this is um um you implants the",
        "start": 2086.639,
        "duration": 6.081
    },
    {
        "text": "cancer cell into the mouse to grow a",
        "start": 2090.359,
        "duration": 4.961
    },
    {
        "text": "tumor this mouse has full immune system",
        "start": 2092.72,
        "duration": 4.6
    },
    {
        "text": "and it's receiving this tumor tumor as",
        "start": 2095.32,
        "duration": 4.48
    },
    {
        "text": "if this is a organ transplant and so",
        "start": 2097.32,
        "duration": 4.279
    },
    {
        "text": "when the tumor grow out we add this",
        "start": 2099.8,
        "duration": 4.44
    },
    {
        "text": "antibody and then um some tumor would",
        "start": 2101.599,
        "duration": 4.881
    },
    {
        "text": "kind of actually disappear other tumor",
        "start": 2104.24,
        "duration": 3.839
    },
    {
        "text": "will still be there then we can collect",
        "start": 2106.48,
        "duration": 3.92
    },
    {
        "text": "the tumor and we do fact sorting on the",
        "start": 2108.079,
        "duration": 4.76
    },
    {
        "text": "tumor to look at the immune cells and we",
        "start": 2110.4,
        "duration": 4.76
    },
    {
        "text": "saw that with the antibody treatment the",
        "start": 2112.839,
        "duration": 4.601
    },
    {
        "text": "tumor has significantly increased the",
        "start": 2115.16,
        "duration": 4.32
    },
    {
        "text": "dendritic cells and the natural koler",
        "start": 2117.44,
        "duration": 5.32
    },
    {
        "text": "cells and also some increase of CD4 T",
        "start": 2119.48,
        "duration": 6.8
    },
    {
        "text": "cells and cd8 T cells and in this tumor",
        "start": 2122.76,
        "duration": 6.2
    },
    {
        "text": "um even if we start the treatment after",
        "start": 2126.28,
        "duration": 5.559
    },
    {
        "text": "the tumor grow out after four doses some",
        "start": 2128.96,
        "duration": 5.32
    },
    {
        "text": "of the tumors would completely go away",
        "start": 2131.839,
        "duration": 4.28
    },
    {
        "text": "and even if we stop the treatment and",
        "start": 2134.28,
        "duration": 3.96
    },
    {
        "text": "wait for another 30 days the tumors",
        "start": 2136.119,
        "duration": 4.041
    },
    {
        "text": "don't really grow back they are still",
        "start": 2138.24,
        "duration": 4.76
    },
    {
        "text": "tumor free and this is quite exciting",
        "start": 2140.16,
        "duration": 4.88
    },
    {
        "text": "our adviser Gordon Freeman who",
        "start": 2143.0,
        "duration": 4.88
    },
    {
        "text": "discovered pd1 pd1 interaction said they",
        "start": 2145.04,
        "duration": 5.279
    },
    {
        "text": "were not aware of any other monoclonal",
        "start": 2147.88,
        "duration": 5.84
    },
    {
        "text": "antibody against this B16 model that can",
        "start": 2150.319,
        "duration": 6.28
    },
    {
        "text": "generate a complete response because B16",
        "start": 2153.72,
        "duration": 5.92
    },
    {
        "text": "has a non antigen presentation defects",
        "start": 2156.599,
        "duration": 5.881
    },
    {
        "text": "and so other checkpoint antibodies don't",
        "start": 2159.64,
        "duration": 4.679
    },
    {
        "text": "has marginal effect but actually our",
        "start": 2162.48,
        "duration": 4.16
    },
    {
        "text": "antibod can curely like totally cure the",
        "start": 2164.319,
        "duration": 5.921
    },
    {
        "text": "tumor and so we decided to test more uh",
        "start": 2166.64,
        "duration": 6.479
    },
    {
        "text": "models and also try uh compare with anti",
        "start": 2170.24,
        "duration": 5.359
    },
    {
        "text": "pd1 and so here I'm only showing you",
        "start": 2173.119,
        "duration": 4.761
    },
    {
        "text": "data on melanoma and non small cell lung",
        "start": 2175.599,
        "duration": 5.321
    },
    {
        "text": "cancer but we have also tested the cd26",
        "start": 2177.88,
        "duration": 6.84
    },
    {
        "text": "colon cancer emt6 and 41 triple negative",
        "start": 2180.92,
        "duration": 5.96
    },
    {
        "text": "press cancer we and we saw very similar",
        "start": 2184.72,
        "duration": 4.76
    },
    {
        "text": "result and in each case you can see the",
        "start": 2186.88,
        "duration": 6.36
    },
    {
        "text": "blue is control antibody red is anti-",
        "start": 2189.48,
        "duration": 8.72
    },
    {
        "text": "pd1 green is anti- igsf8 and purple is",
        "start": 2193.24,
        "duration": 8.28
    },
    {
        "text": "if we have the dose of each drug and and",
        "start": 2198.2,
        "duration": 4.96
    },
    {
        "text": "combine the two like a combination",
        "start": 2201.52,
        "duration": 4.48
    },
    {
        "text": "treatment together and you can see um in",
        "start": 2203.16,
        "duration": 4.64
    },
    {
        "text": "each case actually our antibody has",
        "start": 2206.0,
        "duration": 3.88
    },
    {
        "text": "monotherapy efficacy in controlling",
        "start": 2207.8,
        "duration": 4.799
    },
    {
        "text": "tumor growth and the antibody works the",
        "start": 2209.88,
        "duration": 4.64
    },
    {
        "text": "best when we combine them",
        "start": 2212.599,
        "duration": 4.121
    },
    {
        "text": "together so we did RNA sequence SE",
        "start": 2214.52,
        "duration": 4.04
    },
    {
        "text": "quencing of the tumor and then just uh",
        "start": 2216.72,
        "duration": 6.16
    },
    {
        "text": "look at the RNA expression uh signature",
        "start": 2218.56,
        "duration": 7.32
    },
    {
        "text": "we always see the antibody increase enk",
        "start": 2222.88,
        "duration": 6.239
    },
    {
        "text": "killing increase antigen presentation",
        "start": 2225.88,
        "duration": 5.6
    },
    {
        "text": "increase cell adhesion and increase t-",
        "start": 2229.119,
        "duration": 5.081
    },
    {
        "text": "cell signaling and so actually when we",
        "start": 2231.48,
        "duration": 5.2
    },
    {
        "text": "saw the animal data we didn't have any",
        "start": 2234.2,
        "duration": 4.76
    },
    {
        "text": "idea what this drug is doing or what",
        "start": 2236.68,
        "duration": 4.8
    },
    {
        "text": "this target was doing the mechanism was",
        "start": 2238.96,
        "duration": 5.28
    },
    {
        "text": "kind of figured out over time and this",
        "start": 2241.48,
        "duration": 4.72
    },
    {
        "text": "is the current understanding of this",
        "start": 2244.24,
        "duration": 3.2
    },
    {
        "text": "target",
        "start": 2246.2,
        "duration": 4.48
    },
    {
        "text": "in order for pd1 pdr1 antibodies to work",
        "start": 2247.44,
        "duration": 5.12
    },
    {
        "text": "the cancer cell needs to present its",
        "start": 2250.68,
        "duration": 4.24
    },
    {
        "text": "mutation through MHC onto the cell",
        "start": 2252.56,
        "duration": 4.799
    },
    {
        "text": "surface then t- cell receptor will say",
        "start": 2254.92,
        "duration": 4.36
    },
    {
        "text": "well there's a mutation this is nonself",
        "start": 2257.359,
        "duration": 5.281
    },
    {
        "text": "it will kill the cancer cell um pd1 pdl1",
        "start": 2259.28,
        "duration": 5.079
    },
    {
        "text": "normal interaction is to make the te",
        "start": 2262.64,
        "duration": 4.24
    },
    {
        "text": "cell is kind of a tired or dysfunctional",
        "start": 2264.359,
        "duration": 4.441
    },
    {
        "text": "and so when we have an antibody to block",
        "start": 2266.88,
        "duration": 4.0
    },
    {
        "text": "this then the te- cell can maintain a",
        "start": 2268.8,
        "duration": 5.12
    },
    {
        "text": "very active killing State however a",
        "start": 2270.88,
        "duration": 6.16
    },
    {
        "text": "major mechanism of anti pd1 PDR",
        "start": 2273.92,
        "duration": 5.679
    },
    {
        "text": "resistance is loss of antigen",
        "start": 2277.04,
        "duration": 4.96
    },
    {
        "text": "presentation and this could happen at",
        "start": 2279.599,
        "duration": 5.72
    },
    {
        "text": "the DNA mutation level RNA lower",
        "start": 2282.0,
        "duration": 6.04
    },
    {
        "text": "expression epigenetic silencing or",
        "start": 2285.319,
        "duration": 5.361
    },
    {
        "text": "protein degradation level and every",
        "start": 2288.04,
        "duration": 5.039
    },
    {
        "text": "possibility there actually over two3 of",
        "start": 2290.68,
        "duration": 4.6
    },
    {
        "text": "the tumors have some kind of antigen",
        "start": 2293.079,
        "duration": 4.841
    },
    {
        "text": "presentation defect and so the mutations",
        "start": 2295.28,
        "duration": 4.839
    },
    {
        "text": "are no longer visible to the te- cells",
        "start": 2297.92,
        "duration": 3.76
    },
    {
        "text": "then te- cells don't have a chance to",
        "start": 2300.119,
        "duration": 3.801
    },
    {
        "text": "recognize the mutation infiltrate the",
        "start": 2301.68,
        "duration": 5.28
    },
    {
        "text": "tumor or get activated um even in the",
        "start": 2303.92,
        "duration": 5.96
    },
    {
        "text": "tumors that initially respond to pd1",
        "start": 2306.96,
        "duration": 4.96
    },
    {
        "text": "when they later develop resistance when",
        "start": 2309.88,
        "duration": 4.56
    },
    {
        "text": "people sequence the tumor again 50% of",
        "start": 2311.92,
        "duration": 5.8
    },
    {
        "text": "them have mutations on on this this mhd",
        "start": 2314.44,
        "duration": 6.159
    },
    {
        "text": "class one so it's a major mechanism of",
        "start": 2317.72,
        "duration": 4.96
    },
    {
        "text": "uh immunotherapy",
        "start": 2320.599,
        "duration": 4.48
    },
    {
        "text": "resistance however our our body has a",
        "start": 2322.68,
        "duration": 5.36
    },
    {
        "text": "mechanism against this natural CER cells",
        "start": 2325.079,
        "duration": 5.121
    },
    {
        "text": "are specifically uh supposed to",
        "start": 2328.04,
        "duration": 5.76
    },
    {
        "text": "recognize any cell with anti antigen",
        "start": 2330.2,
        "duration": 5.72
    },
    {
        "text": "presentation defects and kill them",
        "start": 2333.8,
        "duration": 4.12
    },
    {
        "text": "especially if the cell also is under",
        "start": 2335.92,
        "duration": 4.04
    },
    {
        "text": "they release some stress signals and if",
        "start": 2337.92,
        "duration": 4.84
    },
    {
        "text": "they don't express MHC it's a very good",
        "start": 2339.96,
        "duration": 5.08
    },
    {
        "text": "indication the cell is under viral",
        "start": 2342.76,
        "duration": 4.079
    },
    {
        "text": "infection and so normally enk cell would",
        "start": 2345.04,
        "duration": 4.16
    },
    {
        "text": "just kill them and so then we wonder",
        "start": 2346.839,
        "duration": 3.961
    },
    {
        "text": "while in the tumors the cancer cells are",
        "start": 2349.2,
        "duration": 4.48
    },
    {
        "text": "under stress they lose MHC class one why",
        "start": 2350.8,
        "duration": 6.24
    },
    {
        "text": "don't um enk cells kill them and we",
        "start": 2353.68,
        "duration": 5.439
    },
    {
        "text": "found that oh cancer cell is highly",
        "start": 2357.04,
        "duration": 3.76
    },
    {
        "text": "expressing this",
        "start": 2359.119,
        "duration": 5.321
    },
    {
        "text": "igsf8 um and it was only later we found",
        "start": 2360.8,
        "duration": 6.559
    },
    {
        "text": "that it has a natural cooler receptor",
        "start": 2364.44,
        "duration": 5.52
    },
    {
        "text": "and a dendritic cell receptor and the",
        "start": 2367.359,
        "duration": 4.24
    },
    {
        "text": "antibody that we derived from the",
        "start": 2369.96,
        "duration": 4.24
    },
    {
        "text": "patient tumors really block this this",
        "start": 2371.599,
        "duration": 5.041
    },
    {
        "text": "interactions both interactions and",
        "start": 2374.2,
        "duration": 4.32
    },
    {
        "text": "therefore what happens when we dose the",
        "start": 2376.64,
        "duration": 4.12
    },
    {
        "text": "patient or like the mouse tumors at",
        "start": 2378.52,
        "duration": 5.16
    },
    {
        "text": "least in this case is um when you use",
        "start": 2380.76,
        "duration": 5.559
    },
    {
        "text": "this antibody to block the igsf8",
        "start": 2383.68,
        "duration": 5.24
    },
    {
        "text": "interaction with enk cells enk cells get",
        "start": 2386.319,
        "duration": 4.641
    },
    {
        "text": "activated they will kill the cancer",
        "start": 2388.92,
        "duration": 6.159
    },
    {
        "text": "cells that lost mhd class one and if the",
        "start": 2390.96,
        "duration": 6.359
    },
    {
        "text": "the loss is kind of a soft lot like",
        "start": 2395.079,
        "duration": 4.52
    },
    {
        "text": "epigenetic silencing or gene expression",
        "start": 2397.319,
        "duration": 4.321
    },
    {
        "text": "lower expression the cancer cell will",
        "start": 2399.599,
        "duration": 4.041
    },
    {
        "text": "now have to try a little harder to",
        "start": 2401.64,
        "duration": 4.0
    },
    {
        "text": "present their antigen so we will see the",
        "start": 2403.64,
        "duration": 3.719
    },
    {
        "text": "cancer cell kind of increase their",
        "start": 2405.64,
        "duration": 3.959
    },
    {
        "text": "antigen presentation a little bit in",
        "start": 2407.359,
        "duration": 3.881
    },
    {
        "text": "addition the antibody also have a",
        "start": 2409.599,
        "duration": 4.0
    },
    {
        "text": "different receptor under dritic cells",
        "start": 2411.24,
        "duration": 5.079
    },
    {
        "text": "and this antibody can activate the",
        "start": 2413.599,
        "duration": 6.281
    },
    {
        "text": "DC um and so uh dritic cells role is to",
        "start": 2416.319,
        "duration": 5.721
    },
    {
        "text": "do antigen presentation both class one",
        "start": 2419.88,
        "duration": 5.32
    },
    {
        "text": "and class two and also dendritic cell",
        "start": 2422.04,
        "duration": 4.92
    },
    {
        "text": "and enk cells they really help each",
        "start": 2425.2,
        "duration": 4.399
    },
    {
        "text": "other active keep each other active and",
        "start": 2426.96,
        "duration": 4.359
    },
    {
        "text": "once you have increased antigen",
        "start": 2429.599,
        "duration": 3.601
    },
    {
        "text": "presentation both from the cancer cell",
        "start": 2431.319,
        "duration": 4.52
    },
    {
        "text": "and the cell then the te- cells get",
        "start": 2433.2,
        "duration": 4.919
    },
    {
        "text": "activated and some of the tumors when",
        "start": 2435.839,
        "duration": 5.201
    },
    {
        "text": "they don't grow big enough the te- cells",
        "start": 2438.119,
        "duration": 5.041
    },
    {
        "text": "when it's activated is enough to cure",
        "start": 2441.04,
        "duration": 5.52
    },
    {
        "text": "the tumor but then if the tumor is too",
        "start": 2443.16,
        "duration": 5.04
    },
    {
        "text": "big eventually the te- cells will get",
        "start": 2446.56,
        "duration": 4.4
    },
    {
        "text": "tired then you add the pd1 antibody they",
        "start": 2448.2,
        "duration": 4.76
    },
    {
        "text": "will really help the te- cell maintain",
        "start": 2450.96,
        "duration": 3.639
    },
    {
        "text": "the killing as well that's why the two",
        "start": 2452.96,
        "duration": 4.159
    },
    {
        "text": "really have Synergy right also for the",
        "start": 2454.599,
        "duration": 5.361
    },
    {
        "text": "tumors that initially responds to anti",
        "start": 2457.119,
        "duration": 6.801
    },
    {
        "text": "pd1 if we add this antibody to block the",
        "start": 2459.96,
        "duration": 6.6
    },
    {
        "text": "uh igsf8 then the cancer cell cannot",
        "start": 2463.92,
        "duration": 5.199
    },
    {
        "text": "afford to lose MHT to develop resistance",
        "start": 2466.56,
        "duration": 4.519
    },
    {
        "text": "so we also think that the drug will make",
        "start": 2469.119,
        "duration": 5.041
    },
    {
        "text": "the pd1 the cancer respond to pd1 a",
        "start": 2471.079,
        "duration": 4.561
    },
    {
        "text": "little longer",
        "start": 2474.16,
        "duration": 5.199
    },
    {
        "text": "time um so um we we have additional data",
        "start": 2475.64,
        "duration": 6.56
    },
    {
        "text": "on genetic evidence of IGS of8 as an IO",
        "start": 2479.359,
        "duration": 5.161
    },
    {
        "text": "Target I won't have time to discuss this",
        "start": 2482.2,
        "duration": 4.639
    },
    {
        "text": "and so um this antibody because derived",
        "start": 2484.52,
        "duration": 5.12
    },
    {
        "text": "from Human um in the CMC development",
        "start": 2486.839,
        "duration": 4.801
    },
    {
        "text": "process this is you go to a bioreaction",
        "start": 2489.64,
        "duration": 4.199
    },
    {
        "text": "to make a lot of this antibody make it",
        "start": 2491.64,
        "duration": 4.479
    },
    {
        "text": "really clean purify it and put it in a",
        "start": 2493.839,
        "duration": 4.561
    },
    {
        "text": "bottle that you can give to the patient",
        "start": 2496.119,
        "duration": 4.841
    },
    {
        "text": "um we actually had a very smooth",
        "start": 2498.4,
        "duration": 4.56
    },
    {
        "text": "manufacturing process and we got",
        "start": 2500.96,
        "duration": 3.84
    },
    {
        "text": "excellent yield and excellent",
        "start": 2502.96,
        "duration": 4.68
    },
    {
        "text": "developability without any optimization",
        "start": 2504.8,
        "duration": 6.24
    },
    {
        "text": "at the um cdmo company which is quite",
        "start": 2507.64,
        "duration": 6.32
    },
    {
        "text": "unusual this antibod is like really good",
        "start": 2511.04,
        "duration": 5.92
    },
    {
        "text": "um we also did safety uh study in Rat",
        "start": 2513.96,
        "duration": 7.0
    },
    {
        "text": "monkeys and the pharmacology uh dyn like",
        "start": 2516.96,
        "duration": 6.92
    },
    {
        "text": "um metabolism and safety of the drug in",
        "start": 2520.96,
        "duration": 5.84
    },
    {
        "text": "animals also are excellent and so we",
        "start": 2523.88,
        "duration": 5.12
    },
    {
        "text": "started the phase one study uh in",
        "start": 2526.8,
        "duration": 5.72
    },
    {
        "text": "patients with solid tumors um uh in",
        "start": 2529.0,
        "duration": 6.16
    },
    {
        "text": "March of this year and last Friday we",
        "start": 2532.52,
        "duration": 4.68
    },
    {
        "text": "had the safety review meeting of the",
        "start": 2535.16,
        "duration": 4.24
    },
    {
        "text": "highest planned dose cohort so the drug",
        "start": 2537.2,
        "duration": 4.48
    },
    {
        "text": "so far you know it seem seems there's no",
        "start": 2539.4,
        "duration": 5.48
    },
    {
        "text": "safety issues um so we we have a lot of",
        "start": 2541.68,
        "duration": 5.32
    },
    {
        "text": "um confidence you know going into the",
        "start": 2544.88,
        "duration": 3.84
    },
    {
        "text": "next stage of the clinical trial where",
        "start": 2547.0,
        "duration": 4.52
    },
    {
        "text": "we'll focus on specific cancer patients",
        "start": 2548.72,
        "duration": 4.56
    },
    {
        "text": "and also as soon as they finish what's",
        "start": 2551.52,
        "duration": 3.319
    },
    {
        "text": "in the guideline they will be treated",
        "start": 2553.28,
        "duration": 4.2
    },
    {
        "text": "with our drug and we're hoping to see",
        "start": 2554.839,
        "duration": 5.641
    },
    {
        "text": "some efficacy at that time and so far",
        "start": 2557.48,
        "duration": 5.0
    },
    {
        "text": "all the checkpoint Inhibitors are",
        "start": 2560.48,
        "duration": 4.72
    },
    {
        "text": "developed against te- cells nothing has",
        "start": 2562.48,
        "duration": 5.119
    },
    {
        "text": "been developed in enk cells dendritic",
        "start": 2565.2,
        "duration": 5.24
    },
    {
        "text": "cells uh and microage or at least get",
        "start": 2567.599,
        "duration": 4.601
    },
    {
        "text": "approved there are there are drugs in",
        "start": 2570.44,
        "duration": 4.2
    },
    {
        "text": "the clinical trial there is some",
        "start": 2572.2,
        "duration": 4.48
    },
    {
        "text": "difficulty in developing drugs in the",
        "start": 2574.64,
        "duration": 5.679
    },
    {
        "text": "innate immunity because many genes on",
        "start": 2576.68,
        "duration": 6.04
    },
    {
        "text": "enk cells maccrage or dritic cell are",
        "start": 2580.319,
        "duration": 4.441
    },
    {
        "text": "different between human and mouse and so",
        "start": 2582.72,
        "duration": 3.639
    },
    {
        "text": "when you develop a drug it's hard to",
        "start": 2584.76,
        "duration": 4.64
    },
    {
        "text": "really do this invivo testing um also in",
        "start": 2586.359,
        "duration": 4.96
    },
    {
        "text": "human they could also be polymorphic you",
        "start": 2589.4,
        "duration": 4.24
    },
    {
        "text": "know the Cure you they're very",
        "start": 2591.319,
        "duration": 4.681
    },
    {
        "text": "polymorphic um whereas you know we have",
        "start": 2593.64,
        "duration": 5.0
    },
    {
        "text": "this one target it's evolutionarily",
        "start": 2596.0,
        "duration": 5.319
    },
    {
        "text": "conserved and yet it can interact with",
        "start": 2598.64,
        "duration": 5.0
    },
    {
        "text": "both the enk receptor and theic cell",
        "start": 2601.319,
        "duration": 5.0
    },
    {
        "text": "receptor to suppress both cell types we",
        "start": 2603.64,
        "duration": 4.64
    },
    {
        "text": "think it really has a lot of potential",
        "start": 2606.319,
        "duration": 4.161
    },
    {
        "text": "it could be that in the future all the",
        "start": 2608.28,
        "duration": 4.16
    },
    {
        "text": "other immun oncology drugs are going to",
        "start": 2610.48,
        "duration": 5.0
    },
    {
        "text": "be combined with either anti pd1 and our",
        "start": 2612.44,
        "duration": 4.76
    },
    {
        "text": "drug you know as the combo so we think",
        "start": 2615.48,
        "duration": 3.72
    },
    {
        "text": "it could be the next big",
        "start": 2617.2,
        "duration": 4.52
    },
    {
        "text": "checkpoint um and so with our technology",
        "start": 2619.2,
        "duration": 4.2
    },
    {
        "text": "platform we're not just developing this",
        "start": 2621.72,
        "duration": 3.72
    },
    {
        "text": "one drug we're also doing discovery of",
        "start": 2623.4,
        "duration": 4.919
    },
    {
        "text": "other Target all having potential to be",
        "start": 2625.44,
        "duration": 5.28
    },
    {
        "text": "first in class um unfortunately we don't",
        "start": 2628.319,
        "duration": 4.201
    },
    {
        "text": "have enough funding to pursue all of",
        "start": 2630.72,
        "duration": 3.879
    },
    {
        "text": "them so we are now in also discussion",
        "start": 2632.52,
        "duration": 4.12
    },
    {
        "text": "with pharmaceutical companies to see",
        "start": 2634.599,
        "duration": 4.321
    },
    {
        "text": "whether they are interested in giving us",
        "start": 2636.64,
        "duration": 5.08
    },
    {
        "text": "money to um do the discovery",
        "start": 2638.92,
        "duration": 5.28
    },
    {
        "text": "together and so I hope this can convince",
        "start": 2641.72,
        "duration": 3.92
    },
    {
        "text": "you the companies really at the",
        "start": 2644.2,
        "duration": 4.56
    },
    {
        "text": "intersection of High super genomics uh",
        "start": 2645.64,
        "duration": 5.719
    },
    {
        "text": "you know crisper scens Big Data you know",
        "start": 2648.76,
        "duration": 5.52
    },
    {
        "text": "genomics and antibody sequence and",
        "start": 2651.359,
        "duration": 4.841
    },
    {
        "text": "cancer Immunology immunotherapy we're",
        "start": 2654.28,
        "duration": 4.079
    },
    {
        "text": "actually getting a checkpoint um we're",
        "start": 2656.2,
        "duration": 4.879
    },
    {
        "text": "combining the power of genomics and AI",
        "start": 2658.359,
        "duration": 5.2
    },
    {
        "text": "to unlock the hidden antibody signals",
        "start": 2661.079,
        "duration": 4.361
    },
    {
        "text": "already in the patient tumors to develop",
        "start": 2663.559,
        "duration": 3.0
    },
    {
        "text": "therapeutic",
        "start": 2665.44,
        "duration": 3.879
    },
    {
        "text": "the first drug is a monocolonal antibody",
        "start": 2666.559,
        "duration": 5.841
    },
    {
        "text": "but recently um antibody drug conjugate",
        "start": 2669.319,
        "duration": 6.361
    },
    {
        "text": "radio Lian therapy um byp specific",
        "start": 2672.4,
        "duration": 5.679
    },
    {
        "text": "antibody or cell therapy they all",
        "start": 2675.68,
        "duration": 5.76
    },
    {
        "text": "require a tumor specific Target an",
        "start": 2678.079,
        "duration": 6.76
    },
    {
        "text": "antibody to bring this drug to the tumor",
        "start": 2681.44,
        "duration": 5.48
    },
    {
        "text": "and so that's area we think we have some",
        "start": 2684.839,
        "duration": 4.561
    },
    {
        "text": "special expertise to identify novel",
        "start": 2686.92,
        "duration": 5.52
    },
    {
        "text": "targets and antibodies what we envision",
        "start": 2689.4,
        "duration": 4.919
    },
    {
        "text": "could be a long-term thing maybe 20",
        "start": 2692.44,
        "duration": 4.32
    },
    {
        "text": "years from now is some cancer patient",
        "start": 2694.319,
        "duration": 4.961
    },
    {
        "text": "come in we do their tumor sequencing and",
        "start": 2696.76,
        "duration": 5.319
    },
    {
        "text": "based on the analysis we design a",
        "start": 2699.28,
        "duration": 5.44
    },
    {
        "text": "antibody cocktail multiple antibodies",
        "start": 2702.079,
        "duration": 5.48
    },
    {
        "text": "and we encode them in RNA and then put",
        "start": 2704.72,
        "duration": 6.2
    },
    {
        "text": "them in liquid Nano particle like Monna",
        "start": 2707.559,
        "duration": 5.201
    },
    {
        "text": "like you inject that into the patient",
        "start": 2710.92,
        "duration": 4.52
    },
    {
        "text": "and the patient only cells take up the",
        "start": 2712.76,
        "duration": 4.799
    },
    {
        "text": "RNA and produce the antibody cocktail to",
        "start": 2715.44,
        "duration": 4.72
    },
    {
        "text": "cure their tumor I think that would be",
        "start": 2717.559,
        "duration": 5.721
    },
    {
        "text": "quite exciting so in summary I hope this",
        "start": 2720.16,
        "duration": 5.8
    },
    {
        "text": "convinc you that tumor either bulk or",
        "start": 2723.28,
        "duration": 5.36
    },
    {
        "text": "single cell RNA seek profiles are rich",
        "start": 2725.96,
        "duration": 5.32
    },
    {
        "text": "sources of therapeutic antibodies and we",
        "start": 2728.64,
        "duration": 4.959
    },
    {
        "text": "are using AI to really decode a large",
        "start": 2731.28,
        "duration": 4.96
    },
    {
        "text": "cohorts of cancer patients tumors uh B",
        "start": 2733.599,
        "duration": 5.0
    },
    {
        "text": "cell response to unlock the novel",
        "start": 2736.24,
        "duration": 4.839
    },
    {
        "text": "targets and antibodies at the same time",
        "start": 2738.599,
        "duration": 4.321
    },
    {
        "text": "you know we got this antibody to even",
        "start": 2741.079,
        "duration": 3.841
    },
    {
        "text": "work in animals without understanding a",
        "start": 2742.92,
        "duration": 5.12
    },
    {
        "text": "thing about this Gene um and so this is",
        "start": 2744.92,
        "duration": 5.679
    },
    {
        "text": "a really novel innate immune checkpoint",
        "start": 2748.04,
        "duration": 6.36
    },
    {
        "text": "um in the MHC deficient tumors and this",
        "start": 2750.599,
        "duration": 6.0
    },
    {
        "text": "target has receptors on both dendritic",
        "start": 2754.4,
        "duration": 4.56
    },
    {
        "text": "cells and enk cells to suppress DC and",
        "start": 2756.599,
        "duration": 4.921
    },
    {
        "text": "enk cell function and so we develop this",
        "start": 2758.96,
        "duration": 4.8
    },
    {
        "text": "antibody to activate the tumor dendritic",
        "start": 2761.52,
        "duration": 4.799
    },
    {
        "text": "cell and enk cells turn the immune Cod",
        "start": 2763.76,
        "duration": 5.319
    },
    {
        "text": "tumors hard you know in many animal",
        "start": 2766.319,
        "duration": 5.721
    },
    {
        "text": "models we see single agent efficacy and",
        "start": 2769.079,
        "duration": 6.081
    },
    {
        "text": "also this drug is synergistic with anti",
        "start": 2772.04,
        "duration": 6.24
    },
    {
        "text": "pd1 and we also so far has you know run",
        "start": 2775.16,
        "duration": 6.199
    },
    {
        "text": "this safety clinical trial without any",
        "start": 2778.28,
        "duration": 5.76
    },
    {
        "text": "safety issues so I want to thank the",
        "start": 2781.359,
        "duration": 4.561
    },
    {
        "text": "people in the company um this is",
        "start": 2784.04,
        "duration": 4.72
    },
    {
        "text": "definitely a a teamwork um we have a big",
        "start": 2785.92,
        "duration": 4.399
    },
    {
        "text": "research site in Shanghai the",
        "start": 2788.76,
        "duration": 4.44
    },
    {
        "text": "headquarter is in us um we also have a",
        "start": 2790.319,
        "duration": 5.52
    },
    {
        "text": "number of advisors um and also since the",
        "start": 2793.2,
        "duration": 4.159
    },
    {
        "text": "trial is in the clinic I want to thank",
        "start": 2795.839,
        "duration": 3.28
    },
    {
        "text": "the clinical pi and the patients for",
        "start": 2797.359,
        "duration": 5.041
    },
    {
        "text": "giving us the chance um and so I think",
        "start": 2799.119,
        "duration": 6.361
    },
    {
        "text": "this is it uh also at the end um I",
        "start": 2802.4,
        "duration": 6.6
    },
    {
        "text": "closed my lab last year but fortunately",
        "start": 2805.48,
        "duration": 5.879
    },
    {
        "text": "because many former post dos are in",
        "start": 2809.0,
        "duration": 4.2
    },
    {
        "text": "faculty positions they are still",
        "start": 2811.359,
        "duration": 4.2
    },
    {
        "text": "maintaining the software in the lab um",
        "start": 2813.2,
        "duration": 4.28
    },
    {
        "text": "I'm hoping that these tools will still",
        "start": 2815.559,
        "duration": 4.441
    },
    {
        "text": "continue to benefit your research thank",
        "start": 2817.48,
        "duration": 4.92
    },
    {
        "text": "you very",
        "start": 2820.0,
        "duration": 2.4
    },
    {
        "text": "much",
        "start": 2831.839,
        "duration": 3.0
    },
    {
        "text": "there oh thanks that was really",
        "start": 2838.96,
        "duration": 6.2
    },
    {
        "text": "interesting talk I have a a couple",
        "start": 2841.44,
        "duration": 6.52
    },
    {
        "text": "related questions so the first one is",
        "start": 2845.16,
        "duration": 4.28
    },
    {
        "text": "when",
        "start": 2847.96,
        "duration": 6.04
    },
    {
        "text": "you get the sort of unmappable antibody",
        "start": 2849.44,
        "duration": 6.44
    },
    {
        "text": "mrnas is",
        "start": 2854.0,
        "duration": 4.04
    },
    {
        "text": "there you know I mean there can be",
        "start": 2855.88,
        "duration": 4.28
    },
    {
        "text": "errors in sequencing and I just wonder",
        "start": 2858.04,
        "duration": 4.0
    },
    {
        "text": "if like do you have to do you",
        "start": 2860.16,
        "duration": 6.399
    },
    {
        "text": "essentially rely on the sequence to be",
        "start": 2862.04,
        "duration": 6.6
    },
    {
        "text": "perfect or do you need to sort of do",
        "start": 2866.559,
        "duration": 4.241
    },
    {
        "text": "some sort of error correction on your",
        "start": 2868.64,
        "duration": 5.24
    },
    {
        "text": "own ah we don't have to do error",
        "start": 2870.8,
        "duration": 5.92
    },
    {
        "text": "correction because when even in the same",
        "start": 2873.88,
        "duration": 6.16
    },
    {
        "text": "patient um when the B cells are expanded",
        "start": 2876.72,
        "duration": 5.24
    },
    {
        "text": "they go through a a somatic",
        "start": 2880.04,
        "duration": 4.799
    },
    {
        "text": "hypermutation process to have mutations",
        "start": 2881.96,
        "duration": 5.119
    },
    {
        "text": "on antibody to gradually evolve better",
        "start": 2884.839,
        "duration": 5.161
    },
    {
        "text": "antibody so even from the same patient",
        "start": 2887.079,
        "duration": 5.561
    },
    {
        "text": "you will see different sequences as well",
        "start": 2890.0,
        "duration": 4.2
    },
    {
        "text": "they are kind of different from the The",
        "start": 2892.64,
        "duration": 4.439
    },
    {
        "text": "Germ line um but then if we are seeing",
        "start": 2894.2,
        "duration": 5.639
    },
    {
        "text": "this antibody repeatedly from patient we",
        "start": 2897.079,
        "duration": 4.48
    },
    {
        "text": "can kind of know what's the right",
        "start": 2899.839,
        "duration": 4.601
    },
    {
        "text": "sequence to use and also after we get",
        "start": 2901.559,
        "duration": 5.04
    },
    {
        "text": "the antibody tested we do a little bit",
        "start": 2904.44,
        "duration": 4.72
    },
    {
        "text": "optimization as well oh yeah okay so",
        "start": 2906.599,
        "duration": 3.441
    },
    {
        "text": "yeah that was the other thing I was",
        "start": 2909.16,
        "duration": 3.959
    },
    {
        "text": "wondering so when you have to modify",
        "start": 2910.04,
        "duration": 5.76
    },
    {
        "text": "this so that it has this cross species",
        "start": 2913.119,
        "duration": 5.681
    },
    {
        "text": "response um do you like what how",
        "start": 2915.8,
        "duration": 5.12
    },
    {
        "text": "intensive is it to test different",
        "start": 2918.8,
        "duration": 4.64
    },
    {
        "text": "candidates of the cross species antibody",
        "start": 2920.92,
        "duration": 5.159
    },
    {
        "text": "ah so H it depends on the target there",
        "start": 2923.44,
        "duration": 4.44
    },
    {
        "text": "are some targets that we're only getting",
        "start": 2926.079,
        "duration": 4.48
    },
    {
        "text": "the cross human but not Mouse but for",
        "start": 2927.88,
        "duration": 5.16
    },
    {
        "text": "igfa we were very lucky the initial",
        "start": 2930.559,
        "duration": 4.601
    },
    {
        "text": "molecule already binds to human Mouse",
        "start": 2933.04,
        "duration": 4.0
    },
    {
        "text": "with call Affinity then we didn't have",
        "start": 2935.16,
        "duration": 4.8
    },
    {
        "text": "to do the Affinity maturation just to do",
        "start": 2937.04,
        "duration": 6.279
    },
    {
        "text": "the species cross reactivity no it was",
        "start": 2939.96,
        "duration": 7.0
    },
    {
        "text": "very lucky",
        "start": 2943.319,
        "duration": 3.641
    },
    {
        "text": "thanks any questions on this side before",
        "start": 2947.04,
        "duration": 4.279
    },
    {
        "text": "I give it to",
        "start": 2949.44,
        "duration": 4.879
    },
    {
        "text": "attention",
        "start": 2951.319,
        "duration": 3.0
    },
    {
        "text": "okay thank you so much for the talk was",
        "start": 2955.92,
        "duration": 6.36
    },
    {
        "text": "very interesting um so I was wondering",
        "start": 2958.52,
        "duration": 5.2
    },
    {
        "text": "you mentioned that single self",
        "start": 2962.28,
        "duration": 3.559
    },
    {
        "text": "sequencing is also employed in",
        "start": 2963.72,
        "duration": 4.44
    },
    {
        "text": "conjunction with bulk sequencing so in",
        "start": 2965.839,
        "duration": 4.48
    },
    {
        "text": "single cell you able to identify the V",
        "start": 2968.16,
        "duration": 4.88
    },
    {
        "text": "cells so do you for example get the",
        "start": 2970.319,
        "duration": 4.721
    },
    {
        "text": "reads from single cell sequencing make",
        "start": 2973.04,
        "duration": 5.36
    },
    {
        "text": "pseudo bulks and then um assess what",
        "start": 2975.04,
        "duration": 5.44
    },
    {
        "text": "antigen are present in the B cells or",
        "start": 2978.4,
        "duration": 5.24
    },
    {
        "text": "just all of the sequencing together uh",
        "start": 2980.48,
        "duration": 6.2
    },
    {
        "text": "so usually if you sequence a tumor the",
        "start": 2983.64,
        "duration": 5.08
    },
    {
        "text": "cancer cells versus immune cells are",
        "start": 2986.68,
        "duration": 4.919
    },
    {
        "text": "separate in two separate runs we can get",
        "start": 2988.72,
        "duration": 5.04
    },
    {
        "text": "the antigen data as well from the cancer",
        "start": 2991.599,
        "duration": 5.0
    },
    {
        "text": "cells but then the uh immune cells we",
        "start": 2993.76,
        "duration": 4.88
    },
    {
        "text": "will be able to run this trust algorithm",
        "start": 2996.599,
        "duration": 4.641
    },
    {
        "text": "to assemble the antibody sequences they",
        "start": 2998.64,
        "duration": 4.84
    },
    {
        "text": "are still I don't think they are really",
        "start": 3001.24,
        "duration": 4.52
    },
    {
        "text": "kind of helping to train the model the",
        "start": 3003.48,
        "duration": 4.4
    },
    {
        "text": "data for single cell is way too few",
        "start": 3005.76,
        "duration": 4.16
    },
    {
        "text": "compared to what we get from bulk so",
        "start": 3007.88,
        "duration": 3.959
    },
    {
        "text": "most of the training power comes from",
        "start": 3009.92,
        "duration": 4.639
    },
    {
        "text": "the bulk tumors um single cell it's just",
        "start": 3011.839,
        "duration": 4.361
    },
    {
        "text": "nice that the heavy chain and light",
        "start": 3014.559,
        "duration": 3.361
    },
    {
        "text": "chain are already paired so it's easy",
        "start": 3016.2,
        "duration": 4.56
    },
    {
        "text": "for us to synthesize that antibody for",
        "start": 3017.92,
        "duration": 6.04
    },
    {
        "text": "testing thank",
        "start": 3020.76,
        "duration": 3.2
    },
    {
        "text": "you",
        "start": 3024.44,
        "duration": 4.32
    },
    {
        "text": "let me read a question that came in okay",
        "start": 3026.0,
        "duration": 7.88
    },
    {
        "text": "chat r r Ryan is asking for Bic data how",
        "start": 3028.76,
        "duration": 8.079
    },
    {
        "text": "do you match heavy chain sequences with",
        "start": 3033.88,
        "duration": 5.08
    },
    {
        "text": "a corresponding light chain sequence",
        "start": 3036.839,
        "duration": 4.201
    },
    {
        "text": "from the same B cell yeah that's a very",
        "start": 3038.96,
        "duration": 4.72
    },
    {
        "text": "good question right now if you look at",
        "start": 3041.04,
        "duration": 4.88
    },
    {
        "text": "the current AI field for matching heavy",
        "start": 3043.68,
        "duration": 4.56
    },
    {
        "text": "chain light chain they have some power",
        "start": 3045.92,
        "duration": 4.36
    },
    {
        "text": "in naive B cells in the blood but they",
        "start": 3048.24,
        "duration": 4.079
    },
    {
        "text": "have no power once the antibody started",
        "start": 3050.28,
        "duration": 5.839
    },
    {
        "text": "a colonal expansion for us um we are",
        "start": 3052.319,
        "duration": 5.841
    },
    {
        "text": "getting the bulk tumor so right",
        "start": 3056.119,
        "duration": 4.121
    },
    {
        "text": "initially the the heavy chain and light",
        "start": 3058.16,
        "duration": 4.679
    },
    {
        "text": "chain are not matched um we do you know",
        "start": 3060.24,
        "duration": 4.76
    },
    {
        "text": "for a lot of heavy chain we do kind of",
        "start": 3062.839,
        "duration": 4.041
    },
    {
        "text": "think maybe multiple light chains are",
        "start": 3065.0,
        "duration": 3.96
    },
    {
        "text": "possible but if this antibody is",
        "start": 3066.88,
        "duration": 5.04
    },
    {
        "text": "repeatedly expanded in many patient um",
        "start": 3068.96,
        "duration": 4.879
    },
    {
        "text": "you would see the same heavy chain light",
        "start": 3071.92,
        "duration": 4.199
    },
    {
        "text": "chain in many patient we do see a",
        "start": 3073.839,
        "duration": 4.161
    },
    {
        "text": "significant enrichment of that which can",
        "start": 3076.119,
        "duration": 4.041
    },
    {
        "text": "help us narrow down the the choice to",
        "start": 3078.0,
        "duration": 5.28
    },
    {
        "text": "test but it's certainly not perfect yet",
        "start": 3080.16,
        "duration": 4.8
    },
    {
        "text": "that's why single cell data is very",
        "start": 3083.28,
        "duration": 4.24
    },
    {
        "text": "helpful for",
        "start": 3084.96,
        "duration": 8.119
    },
    {
        "text": "us yeah so in your AI model uh you don't",
        "start": 3087.52,
        "duration": 9.319
    },
    {
        "text": "have you don't use any specific antigen",
        "start": 3093.079,
        "duration": 7.24
    },
    {
        "text": "antibody gr truth labels but there's",
        "start": 3096.839,
        "duration": 6.201
    },
    {
        "text": "actually a small number of antigen",
        "start": 3100.319,
        "duration": 6.121
    },
    {
        "text": "antibod pair that we do know the exact",
        "start": 3103.04,
        "duration": 7.319
    },
    {
        "text": "label so do you uh think spiking in",
        "start": 3106.44,
        "duration": 6.0
    },
    {
        "text": "those uh",
        "start": 3110.359,
        "duration": 6.801
    },
    {
        "text": "antibody um sequence antibody data with",
        "start": 3112.44,
        "duration": 7.679
    },
    {
        "text": "uh explicit antigen labels could",
        "start": 3117.16,
        "duration": 4.88
    },
    {
        "text": "potentially improve the accuracy of your",
        "start": 3120.119,
        "duration": 4.24
    },
    {
        "text": "AI model U we yeah that's a good",
        "start": 3122.04,
        "duration": 4.68
    },
    {
        "text": "question it depends on how that antibod",
        "start": 3124.359,
        "duration": 4.681
    },
    {
        "text": "is generated because some of these are",
        "start": 3126.72,
        "duration": 4.839
    },
    {
        "text": "generated in moue or camel and then they",
        "start": 3129.04,
        "duration": 4.64
    },
    {
        "text": "humanized I don't think they will follow",
        "start": 3131.559,
        "duration": 4.921
    },
    {
        "text": "the same rule as a human antibody but if",
        "start": 3133.68,
        "duration": 6.76
    },
    {
        "text": "it's uh like a from Penning like a fasia",
        "start": 3136.48,
        "duration": 5.96
    },
    {
        "text": "Penning but it has to be a synthetic",
        "start": 3140.44,
        "duration": 4.879
    },
    {
        "text": "library from well no no not from from",
        "start": 3142.44,
        "duration": 4.8
    },
    {
        "text": "natural human be cells for a painting",
        "start": 3145.319,
        "duration": 4.881
    },
    {
        "text": "Library maybe you will help but again",
        "start": 3147.24,
        "duration": 5.24
    },
    {
        "text": "it's a very small subset compared to the",
        "start": 3150.2,
        "duration": 3.8
    },
    {
        "text": "100 million anbody that we're are",
        "start": 3152.48,
        "duration": 5.24
    },
    {
        "text": "getting from tumors um we we can use it",
        "start": 3154.0,
        "duration": 5.599
    },
    {
        "text": "to kind of help us validate but we",
        "start": 3157.72,
        "duration": 3.359
    },
    {
        "text": "haven't you know I don't think it's",
        "start": 3159.599,
        "duration": 4.96
    },
    {
        "text": "going to sway the training as",
        "start": 3161.079,
        "duration": 3.48
    },
    {
        "text": "much um surely I have two more questions",
        "start": 3165.599,
        "duration": 7.081
    },
    {
        "text": "coming in online um has two let me read",
        "start": 3169.0,
        "duration": 6.2
    },
    {
        "text": "her second question first uh you mention",
        "start": 3172.68,
        "duration": 4.879
    },
    {
        "text": "mentioned High Affinity yet no safety",
        "start": 3175.2,
        "duration": 6.08
    },
    {
        "text": "issues in in face one trials uh is",
        "start": 3177.559,
        "duration": 8.081
    },
    {
        "text": "asking for popular pd1 like uh Target",
        "start": 3181.28,
        "duration": 8.88
    },
    {
        "text": "such as Kuda and Tiel adverse effects",
        "start": 3185.64,
        "duration": 7.12
    },
    {
        "text": "especially Ada always affect a large",
        "start": 3190.16,
        "duration": 4.88
    },
    {
        "text": "fraction of patients is it not SE in",
        "start": 3192.76,
        "duration": 5.839
    },
    {
        "text": "your case um so right now we have not",
        "start": 3195.04,
        "duration": 5.92
    },
    {
        "text": "treated our patient enough time in order",
        "start": 3198.599,
        "duration": 5.52
    },
    {
        "text": "for Ada you need a longer time treatment",
        "start": 3200.96,
        "duration": 7.24
    },
    {
        "text": "so for our SA 50 it's a 21 cycle and",
        "start": 3204.119,
        "duration": 6.521
    },
    {
        "text": "then if it's safe you know at this stage",
        "start": 3208.2,
        "duration": 4.04
    },
    {
        "text": "what we care about is patient don't",
        "start": 3210.64,
        "duration": 4.6
    },
    {
        "text": "develop cyto storm and die or have very",
        "start": 3212.24,
        "duration": 6.04
    },
    {
        "text": "severe side effect and we don't see that",
        "start": 3215.24,
        "duration": 5.28
    },
    {
        "text": "uh at least in the first 21 days in",
        "start": 3218.28,
        "duration": 3.92
    },
    {
        "text": "order to see whether there's Ada is",
        "start": 3220.52,
        "duration": 4.319
    },
    {
        "text": "going to be much longer time but so far",
        "start": 3222.2,
        "duration": 5.919
    },
    {
        "text": "if you look at the AI companies or a",
        "start": 3224.839,
        "duration": 6.24
    },
    {
        "text": "Pharma trying to develop antibodies",
        "start": 3228.119,
        "duration": 5.841
    },
    {
        "text": "without immunogenicity or the likelihood",
        "start": 3231.079,
        "duration": 5.361
    },
    {
        "text": "to generate Ada their main goal is to",
        "start": 3233.96,
        "duration": 4.8
    },
    {
        "text": "make this antibody look as human as",
        "start": 3236.44,
        "duration": 5.0
    },
    {
        "text": "possible which naturally our antibody is",
        "start": 3238.76,
        "duration": 3.88
    },
    {
        "text": "human",
        "start": 3241.44,
        "duration": 5.0
    },
    {
        "text": "already yeah any other question okay",
        "start": 3242.64,
        "duration": 6.64
    },
    {
        "text": "while I'm walking over let me say J has",
        "start": 3246.44,
        "duration": 4.28
    },
    {
        "text": "a technical question one of your",
        "start": 3249.28,
        "duration": 4.799
    },
    {
        "text": "survival plots and if they are 10 m or",
        "start": 3250.72,
        "duration": 6.599
    },
    {
        "text": "fewer how did you get P value of maybe",
        "start": 3254.079,
        "duration": 5.161
    },
    {
        "text": "so you mean this one",
        "start": 3257.319,
        "duration": 5.921
    },
    {
        "text": "18 um so each arm for this we have eight",
        "start": 3259.24,
        "duration": 6.16
    },
    {
        "text": "mice but we have done many many",
        "start": 3263.24,
        "duration": 4.04
    },
    {
        "text": "different models many many different",
        "start": 3265.4,
        "duration": 4.48
    },
    {
        "text": "conditions and also CD4 depletion CDA",
        "start": 3267.28,
        "duration": 4.96
    },
    {
        "text": "depletion and Casa depletion uh",
        "start": 3269.88,
        "duration": 4.84
    },
    {
        "text": "different combos so we are fairly",
        "start": 3272.24,
        "duration": 5.359
    },
    {
        "text": "confident about the animal data we we I",
        "start": 3274.72,
        "duration": 5.079
    },
    {
        "text": "think overall the different animals",
        "start": 3277.599,
        "duration": 3.921
    },
    {
        "text": "we're talking about I'm only showing you",
        "start": 3279.799,
        "duration": 3.52
    },
    {
        "text": "a subset we have like probably close to",
        "start": 3281.52,
        "duration": 7.76
    },
    {
        "text": "300 animals for data um have look at the",
        "start": 3283.319,
        "duration": 9.081
    },
    {
        "text": "maybe pd1 or in your case like",
        "start": 3289.28,
        "duration": 6.0
    },
    {
        "text": "igsf8 antibody resistant chome or",
        "start": 3292.4,
        "duration": 4.84
    },
    {
        "text": "something like that and then do you see",
        "start": 3295.28,
        "duration": 3.519
    },
    {
        "text": "like the kind of evolution with the",
        "start": 3297.24,
        "duration": 4.0
    },
    {
        "text": "antigens that existing in the tumor the",
        "start": 3298.799,
        "duration": 4.76
    },
    {
        "text": "tumor cell acquire additional mutations",
        "start": 3301.24,
        "duration": 4.839
    },
    {
        "text": "in the anine so that the antibody you",
        "start": 3303.559,
        "duration": 5.121
    },
    {
        "text": "design actually also like escaped from",
        "start": 3306.079,
        "duration": 6.841
    },
    {
        "text": "the Cuma cells uh so far we haven't seen",
        "start": 3308.68,
        "duration": 7.32
    },
    {
        "text": "much specific like point mutation IGS",
        "start": 3312.92,
        "duration": 5.159
    },
    {
        "text": "of8 but this Gene is frequently",
        "start": 3316.0,
        "duration": 4.88
    },
    {
        "text": "Amplified in the tumors we think that's",
        "start": 3318.079,
        "duration": 5.561
    },
    {
        "text": "also a potential evasion mechanism so",
        "start": 3320.88,
        "duration": 5.159
    },
    {
        "text": "this Gene normally is expressed in brain",
        "start": 3323.64,
        "duration": 5.28
    },
    {
        "text": "and neuronal tissues because our brain",
        "start": 3326.039,
        "duration": 5.32
    },
    {
        "text": "you know the they the neuronal cells",
        "start": 3328.92,
        "duration": 4.8
    },
    {
        "text": "don't regenerate and so no matter what",
        "start": 3331.359,
        "duration": 3.96
    },
    {
        "text": "mutation happens you don't want your",
        "start": 3333.72,
        "duration": 4.04
    },
    {
        "text": "immune system to attack this and so",
        "start": 3335.319,
        "duration": 5.52
    },
    {
        "text": "neurons don't express mhd class one and",
        "start": 3337.76,
        "duration": 5.44
    },
    {
        "text": "that essentially suppress the adaptive",
        "start": 3340.839,
        "duration": 4.96
    },
    {
        "text": "immunity and it also highly Express",
        "start": 3343.2,
        "duration": 5.08
    },
    {
        "text": "igsf8 and that will suppress innate",
        "start": 3345.799,
        "duration": 5.0
    },
    {
        "text": "immunity and we hypothesize the cancer",
        "start": 3348.28,
        "duration": 4.16
    },
    {
        "text": "cell just kind of learn it from the",
        "start": 3350.799,
        "duration": 4.401
    },
    {
        "text": "brain as well when they lose mhd class",
        "start": 3352.44,
        "duration": 5.84
    },
    {
        "text": "why thank you so",
        "start": 3355.2,
        "duration": 3.08
    },
    {
        "text": "much uh thank you very nice talk I have",
        "start": 3365.0,
        "duration": 5.88
    },
    {
        "text": "a one question so uh you can deduce the",
        "start": 3367.44,
        "duration": 6.84
    },
    {
        "text": "uh antibody uh sequence from the public",
        "start": 3370.88,
        "duration": 7.32
    },
    {
        "text": "data so how do you find all the all the",
        "start": 3374.28,
        "duration": 4.96
    },
    {
        "text": "um",
        "start": 3378.2,
        "duration": 4.68
    },
    {
        "text": "antigen in from public data uh the",
        "start": 3379.24,
        "duration": 5.839
    },
    {
        "text": "antigen is in the tumor profile as well",
        "start": 3382.88,
        "duration": 5.36
    },
    {
        "text": "well oh this is the a protein sequence",
        "start": 3385.079,
        "duration": 7.0
    },
    {
        "text": "or uh there are you know RNA sequence",
        "start": 3388.24,
        "duration": 6.28
    },
    {
        "text": "and also other like mutations and other",
        "start": 3392.079,
        "duration": 4.641
    },
    {
        "text": "immune signals that we are considering",
        "start": 3394.52,
        "duration": 4.48
    },
    {
        "text": "in that as well we we also do our",
        "start": 3396.72,
        "duration": 4.24
    },
    {
        "text": "additional annotation on the tumor as",
        "start": 3399.0,
        "duration": 6.839
    },
    {
        "text": "well okay thank you but it's it's all",
        "start": 3400.96,
        "duration": 4.879
    },
    {
        "text": "there all right um maybe I'll take the",
        "start": 3408.2,
        "duration": 4.399
    },
    {
        "text": "honor of asking your last question shley",
        "start": 3410.839,
        "duration": 4.2
    },
    {
        "text": "could you comment more about the um tu",
        "start": 3412.599,
        "duration": 5.281
    },
    {
        "text": "type specificity like which types will",
        "start": 3415.039,
        "duration": 5.681
    },
    {
        "text": "stands to benefit in the near future um",
        "start": 3417.88,
        "duration": 5.719
    },
    {
        "text": "so you know pv1 has been approved in 18",
        "start": 3420.72,
        "duration": 5.8
    },
    {
        "text": "different uh indications but in each",
        "start": 3423.599,
        "duration": 5.321
    },
    {
        "text": "indication only a minority of patients",
        "start": 3426.52,
        "duration": 5.24
    },
    {
        "text": "benefit and so now we are doing this",
        "start": 3428.92,
        "duration": 4.919
    },
    {
        "text": "trial we are kind of planning for the",
        "start": 3431.76,
        "duration": 3.88
    },
    {
        "text": "next stage when we have to settle on a",
        "start": 3433.839,
        "duration": 4.321
    },
    {
        "text": "specific cancer type um what we are",
        "start": 3435.64,
        "duration": 5.479
    },
    {
        "text": "looking for is um some cancer types",
        "start": 3438.16,
        "duration": 5.48
    },
    {
        "text": "right now we cannot use igfa to select a",
        "start": 3441.119,
        "duration": 4.841
    },
    {
        "text": "patient because FDA need retrospective",
        "start": 3443.64,
        "duration": 4.76
    },
    {
        "text": "study to show that patient with higher",
        "start": 3445.96,
        "duration": 4.839
    },
    {
        "text": "igsf8 will benefit more from the drug",
        "start": 3448.4,
        "duration": 4.439
    },
    {
        "text": "before we can use it as a biomarker for",
        "start": 3450.799,
        "duration": 4.28
    },
    {
        "text": "patient selection what we can do is to",
        "start": 3452.839,
        "duration": 4.76
    },
    {
        "text": "ask which cancer types en reach for",
        "start": 3455.079,
        "duration": 5.801
    },
    {
        "text": "higher IGS of8 in general like melanoma",
        "start": 3457.599,
        "duration": 5.96
    },
    {
        "text": "uh en reach for MHT class one loss which",
        "start": 3460.88,
        "duration": 6.0
    },
    {
        "text": "is like lung cancer and colon cancer uh",
        "start": 3463.559,
        "duration": 6.881
    },
    {
        "text": "and also which cancer types uh have a",
        "start": 3466.88,
        "duration": 5.719
    },
    {
        "text": "met clinical need we we ask the clinics",
        "start": 3470.44,
        "duration": 3.679
    },
    {
        "text": "you know do you see patients you know",
        "start": 3472.599,
        "duration": 3.321
    },
    {
        "text": "what line of treat treatment can we get",
        "start": 3474.119,
        "duration": 4.281
    },
    {
        "text": "so normally for each additional line of",
        "start": 3475.92,
        "duration": 4.639
    },
    {
        "text": "treatment uh the patient gets sicker and",
        "start": 3478.4,
        "duration": 4.719
    },
    {
        "text": "they have waited even longer time there",
        "start": 3480.559,
        "duration": 4.48
    },
    {
        "text": "there's usually a 10% drop in their",
        "start": 3483.119,
        "duration": 4.041
    },
    {
        "text": "response to a immunal therapy so we want",
        "start": 3485.039,
        "duration": 4.201
    },
    {
        "text": "to go to as early line of treatment as",
        "start": 3487.16,
        "duration": 4.56
    },
    {
        "text": "possible so we are asking is this",
        "start": 3489.24,
        "duration": 4.96
    },
    {
        "text": "disease very crowded too many other",
        "start": 3491.72,
        "duration": 4.399
    },
    {
        "text": "investigational drugs being tested then",
        "start": 3494.2,
        "duration": 3.96
    },
    {
        "text": "we don't go to those so it's a kind of",
        "start": 3496.119,
        "duration": 5.081
    },
    {
        "text": "complicated decision uh also fairly",
        "start": 3498.16,
        "duration": 5.0
    },
    {
        "text": "frequently in the US we can get enough",
        "start": 3501.2,
        "duration": 5.52
    },
    {
        "text": "patients that's a kind of holistic",
        "start": 3503.16,
        "duration": 6.0
    },
    {
        "text": "consideration good good complicated",
        "start": 3506.72,
        "duration": 6.04
    },
    {
        "text": "decision at end note please join me in",
        "start": 3509.16,
        "duration": 6.76
    },
    {
        "text": "thanking Dr Shirley",
        "start": 3512.76,
        "duration": 3.16
    },
    {
        "text": "Leo",
        "start": 3520.76,
        "duration": 3.0
    }
]